2014-01-02 19:26:24 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fbd36b0527d29f0253546b7bfcb57f3 |
|
2014-01-02 19:29:28 |
Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30d130ae949528307895799d5f9b9658 |
|
2014-01-03 15:46:43 |
Clarification to Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/722f2fe24a676421b51273dfbbe6ef93 |
|
2014-01-15 11:43:39 |
Westcoast Launches Novel Hemostyp Gauze |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0aec616d46c2a627d931c985d755d761 |
|
2014-01-20 12:13:11 |
Suda Ltd Appoints Technical Manager |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d367853b89e60e68a63b35ea4d4bc5b |
Company Administration - Other
|
2014-01-22 13:09:03 |
Westcoast Expands Aged Care Activities |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac1a08f7f1939e232ba1948afde84e52 |
|
2014-01-23 11:57:53 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6c408bf57d73634d4b9ef4f444710b44 |
Commitments Test Entity - Fourth Quarter Report
|
2014-02-13 12:13:11 |
SUDA retains US regulatory consultant |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0c331a83f292342f13b1324dbb2c21e |
Company Administration - Other
|
2014-02-14 19:28:26 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/045718d87323fcb1cd244bad834a391b |
|
2014-02-17 09:57:53 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ef690d82c29f8b6b6e8031d1cc523f5 |
|
2014-02-21 15:57:54 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5458a5cd8d0fd63d89cf1b92ad5516c0 |
Ceasing to be a substantial holder
|
2014-02-21 18:55:53 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bcedcad791589a52a5387d4ca7e86b92 |
|
2014-02-26 19:18:16 |
Appendix 4D Half Year Ended 31 December 2013 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/438b4ca894a2f9b7c6ba501f2d4c4d47 |
Half Year Directors' Statement
Half Year Directors' Report
|
2014-03-10 13:54:51 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee688417a59c24eb0836b2c2d46bc007 |
|
2014-03-17 17:05:03 |
Placement Capacity Under Listing Rules |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4fb530226cd38d0b8936999f92a2a29 |
|
2014-03-18 08:26:53 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05484abfbd6bbb21292684a92e8a92d6 |
Change in substantial holding
|
2014-03-19 17:43:41 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6efaabd7aba2a20a14aa311eca448e2 |
|
2014-03-24 14:05:04 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45af63681fe25014faf81b5e704f66af |
|
2014-04-01 09:25:21 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6accb4d3bc35e215a6f15643b6a8e9c6 |
Company Administration - Other
|
2014-04-02 09:07:06 |
Appointment of Clinical Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f861288c1a53c2ac636ea16c63681287 |
Company Administration - Other
|
2014-04-11 12:27:25 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9edd379e664370a0104d2c90f629eb3 |
Notice of General Meeting
|
2014-04-22 12:27:26 |
Change of Share Registry address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f54275a9a24c538f68b42cc213d8b49f |
Details of Share Registry address
|
2014-04-30 16:07:03 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f13da0502fdac984429c4596a8d31f1 |
Commitments Test Entity - Third Quarter Report
|
2014-05-01 08:20:49 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19471fb0ff8605de936d3cfa3d1b5f93 |
|
2014-05-01 09:34:31 |
Westcoast Expands To East Coast |
1 |
https://app.sharelinktechnologies.com/announcement/asx/014e3d212a0b8fa6a8b24ee5fae6ed86 |
|
2014-05-02 09:32:28 |
Suda Ltd Long Term Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51d8016bdfce12ffd51c33b6446710ff |
Company Administration - Other
|
2014-05-09 11:20:15 |
Shareholder Update and General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfc2bb14c39fc6143dda9fa8f61ac2b8 |
|
2014-05-09 15:28:27 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ce966aa2892f96a02ce825f02e99d8f |
|
2014-05-15 15:57:55 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35f3b82b1e976c66343650239a950d93 |
|
2014-05-15 15:58:57 |
Change of Director's Interest Notices |
0 |
https://app.sharelinktechnologies.com/announcement/asx/687a2dcac06dfa8c916d0dcdff03ff1c |
Change of Director's Interest Notice
|
2014-05-26 16:37:35 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97dba28a727a12d8b097309c64a34ba1 |
|
2014-06-06 12:15:13 |
Investor Road Show Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e6ba296689a52a42e68200b3f9e99ad |
|
2014-06-13 11:35:34 |
Suda Appoints Advisor For ArTiMist Negotiations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/472920da22486548f8b274369cf9b2d8 |
Company Administration - Other
|
2014-06-17 11:47:41 |
Suda Commences Outreach In The USA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ccb3a5ea93e433d40f8e05cab78d6e22 |
|
2014-06-23 12:45:44 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fe4ae485bae85ff4b9c3e66e9ccd4f6 |
|
2014-06-23 12:51:50 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/699c128874c3d0a0336c0110b8f0bfaf |
Change of Director's Interest Notice
|
2014-06-27 14:19:17 |
Successful Outreach in USA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b50a0a5afc774ac365f5c2beea734cf |
|
2014-07-01 08:26:13 |
Underwriting of Options |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d37607baefbbdfbd57af11ebc89ae38d |
Company Administration - Other
|
2014-07-03 18:59:51 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d94a65c67b0626843f53eb6a1cdc7fc |
Change of Director's Interest Notice
|
2014-07-14 13:19:17 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ddad2813f7e7da98123fe56d5b39d09e |
|
2014-07-14 13:22:21 |
Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dded43c881085fb7b8e6dd0b693a0724 |
|
2014-07-14 13:24:22 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3685826d6c38dd22c6e61c30e55d2d43 |
Change of Director's Interest Notice
|
2014-07-15 16:59:57 |
Bergen Funding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42c880b7908d09ce1897b850768f70a0 |
|
2014-07-21 19:09:07 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5143afe52d6cf3a8fa0a89b63c954c6 |
Change in substantial holding
|
2014-07-24 10:20:16 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ff9c0e71bf5d54da9f4760fe5bde0f91 |
Commitments Test Entity - Fourth Quarter Report
|
2014-08-08 16:06:05 |
Resignation of a Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5835b27f6b44cdbbd5142e058558ea4 |
Director Appointment/Resignation
|
2014-08-08 16:13:11 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ecb1a7bf77b64ac9e13bb1c0d43b3df0 |
Final Director's Interest Notice
|
2014-08-12 18:37:35 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4456eb3b67d0388cb68f48cef8a52c69 |
|
2014-08-12 18:42:37 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d3c433eff2bc1267712f888d9081c50 |
|
2014-08-21 08:56:51 |
Update On ArTiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b76e72422e12d8d45d062ecbcba1373d |
|
2014-08-29 13:58:53 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72ff8efcef2a242db2670d9dc4c74d6f |
|
2014-09-15 09:02:58 |
ArTiMist Phase III presentation at ASTMH Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c2a0978fec9aab0ee09077ea87f3eb2 |
|
2014-09-16 09:01:49 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18bcef996fb80bd0f39506c1573891cc |
|
2014-09-18 09:11:10 |
SUDA Achieves ISO9001 Certification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ec0d09e3d05346997cb9e118ff73a20 |
|
2014-09-23 11:20:18 |
Investor Road Show Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f975a31f4ed31370755068d13f13838 |
|
2014-09-25 08:32:21 |
AusBiotech Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/211f08d8fd31fe1756ad34fa560c3a28 |
|
2014-09-26 10:38:36 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df2f426832b35b7d9553e7143bcf721b |
Full Year Directors' Statement
Full Year Directors' Report
|
2014-10-03 10:59:57 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1654db86a04542f604cfc94b71ed315f |
|
2014-10-03 11:01:59 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8328cc1a60f60cb9631cb03ff363c843 |
|
2014-10-24 11:57:55 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65ce1bf0b34cb1c29d533fc119ee9098 |
Notice of Annual General Meeting
|
2014-10-29 12:16:10 |
SUDA Attending Two Key Partnering Events |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09441284923b359e872b3b54ece9ac66 |
|
2014-10-30 12:13:09 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fda3655876a4c767f40fbdfc9c8b00d9 |
Commitments Test Entity - First Quarter Report
|
2014-11-06 11:54:51 |
Suda Presents ArTiMist at ASTMH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/015701457aae7d4a9008d52beb19b670 |
Company Administration - Other
|
2014-11-18 19:02:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65e3b873780b9adf344080bb0a00c27d |
|
2014-11-18 19:25:22 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3761860997a41ab3f709a21a4bccdc34 |
|
2014-11-21 19:31:30 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ab9c04364fffea48f2b678d2298934f |
Change in substantial holding
|
2014-11-27 13:32:30 |
Suda 2014 AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/351d6dfa084b301c885951529f06273f |
Chairman's Address to Shareholders
|
2014-11-27 15:56:54 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e7f79cd6fb35fc6ccf4f8eed77c4f25 |
|
2014-12-01 14:28:26 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0d10cf78b1f8b6f71f5d05576f27706 |
|
2014-12-01 14:31:28 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2227f03ba59f178bc2fcaca0937e432e |
Change of Director's Interest Notice
|
2014-12-05 08:25:52 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa5dce80b7e2a0764f45efe0c8e681bf |
Change in substantial holding
|
2015-01-08 12:15:09 |
Suda Enters Into Licence Agreement With Amherst |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f9ae325eb3a7bd24ed26bf1795ce163 |
|
2015-01-22 13:18:13 |
Investor presentation - Amherst Pharma collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91efb5d5fd821fecaf8708ba6f4cff79 |
|
2015-01-22 14:42:39 |
Amended investor presentation - Amherst Pharma collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4d4258e816768ee22f8d961323addb9 |
|
2015-01-30 11:30:26 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b242875b5ff09a5e7b7ad46894ead82c |
Commitments Test Entity - Second Quarter Report
|
2015-01-30 13:14:11 |
Suda Granted First Patent For Sildenafil In Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38cfc81c5b68a62471ef8d49957a4482 |
|
2015-02-23 12:11:07 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73ef0f8e1dce640e9051e34de88eb8eb |
|
2015-02-24 12:16:15 |
Investor Road Show Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6edeb258c876b96955a81c75406e340 |
|
2015-02-27 17:07:03 |
Appendix 4D Half Year Ended 31 December 2014 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4bff642f9c66c6fec1bb36e647155b42 |
Half Year Directors' Statement
Half Year Directors' Report
|
2015-03-09 12:22:21 |
Suda Attending Bio-Europe Spring Partnering Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a56d7c2924a290462d44d66490b8f8b5 |
|
2015-03-25 08:27:56 |
SUDA Progresses Business Development Activities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98feb0053e55bc1ea022c221553a8e3d |
|
2015-03-26 09:30:22 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b76fa0522782c9c9adfcd376c81d7eb |
|
2015-03-27 12:31:22 |
Suda completes $5.3m capital raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/326be1b85cfc0cf2a72250848085da32 |
|
2015-04-02 19:35:32 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e7abf6f2f22196d2299558f011204e5 |
|
2015-04-02 19:36:33 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba722e02fa8add2526a2f2f447efc2b9 |
|
2015-04-10 12:04:02 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6297890b408eba6cfa5bfc71df01fa55 |
|
2015-04-10 12:05:04 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b37b58bd812629b694a9ac9c22c6653 |
|
2015-04-21 12:19:17 |
SUDA establishes clinical advisory board for migraine spray |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdd4816204358b1b74b2f294fdab2772 |
|
2015-04-22 16:07:04 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01fce125497d48c552f94c7c7ea03cd4 |
|
2015-04-22 18:20:19 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d9519308f7bf0d13996618bcea15dac |
|
2015-04-24 09:19:08 |
SUDA announces ArTiMist peer-reviewed publications |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8bb2a1cb6fc3b0ea38678a0f64c3824c |
|
2015-04-29 17:11:10 |
Appendix 3B and Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d447ea7f3418a71bb91089d06135bc10 |
|
2015-04-30 17:33:32 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/827466fe273bc733c9e3d911d6b6e8f4 |
Commitments Test Entity - Third Quarter Report
|
2015-05-27 08:24:06 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3017ff4d764b7adb3b41c9e9427fd0b |
Change in substantial holding
|
2015-06-09 08:26:06 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f900fa52d2af8076b9daaa01930d4778 |
|
2015-06-09 08:55:50 |
BBR audio webcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01573b44f925c62d988c519c427487ea |
|
2015-06-09 08:55:50 |
Shareholder update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f96afa2b7a569490dc750bca43601fff |
|
2015-06-25 08:27:46 |
SUDA Establishes CAB For Erectile Dysfunction Oral Spray |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07ee4c7295c6f26a87f5f6c0bccf195e |
Company Administration - Other
|
2015-06-26 13:51:51 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/945491a6af1f8129f6154f494f563eb7 |
Change of Director's Interest Notice
|
2015-06-29 12:28:21 |
SUDA progresses business development at BIO 2015 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06c9f9e8ba74cce7cbb5e109bc31886c |
|
2015-07-27 12:18:12 |
SUDA granted US patent for SUD-002 oral spray |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b9d3923d922ef40a96e4321ea22b79a |
|
2015-07-28 11:24:21 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c886c9e6d8bcb0002fb5382d86004da |
Commitments Test Entity - Fourth Quarter Report
|
2015-07-31 10:05:57 |
SUDA granted African patent for ArTiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b34a9a536451b0ddb13283686c550074 |
|
2015-08-06 09:09:08 |
SUDA receives positive response from FDA regarding SUD-001 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9de546ae947fc0120f8863a1da7a14a |
|
2015-08-14 11:10:06 |
SUDA investor initiative and presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa10b8aeb9515d78b1ce24548a2b04a8 |
|
2015-08-26 09:08:02 |
SUDA takes full control of ArTiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/182e8daddd6578bc4d86b998012151b3 |
|
2015-08-27 09:20:02 |
SUDA announces ArTiMist clinical publication |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a70e2bc121fc0c416c5c7dbf1deb2092 |
|
2015-08-31 16:14:58 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43482b9fcf23a97ba516022cfff609a5 |
|
2015-09-02 12:12:10 |
Appendix 3B and Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4351f2d6110e623201e6310b6c5ce7d2 |
|
2015-09-30 13:42:40 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/215a655c49377c45f4cd59071bc69dde |
|
2015-09-30 13:44:43 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60271d68934be9162b0deda532183920 |
Full Year Directors' Statement
Full Year Directors' Report
|
2015-10-05 15:21:19 |
SUDA releases video from Singapore investor showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/849908f25b61d5d11e3057f57b8d3418 |
|
2015-10-08 10:06:55 |
SUDA allowed first USA patent for SUD-003 and SUD-004 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96e716c7cae2fbfe9630b713169c89d3 |
|
2015-10-09 13:28:27 |
Update on Convertible Notes and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/643ce38eae66d8ef910b15bed21ce987 |
|
2015-10-15 10:14:08 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c827c07dc51cdb52ec718c565a579fe |
|
2015-10-16 10:13:02 |
SUDA LTD Audio Webcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68cc3d477740876f28031eb64b37de23 |
|
2015-10-16 14:04:01 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04274713b115e19e5b2bc4fe1b1e8092 |
Notice of Annual General Meeting
|
2015-10-21 13:55:53 |
Update on 2013 Convertible Notes and Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a2b122eafba4eb77f81f4e0c69d1925 |
Change of Director's Interest Notice
|
2015-10-26 10:23:06 |
SUDA to present at Hong Kong investor showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3c7bb81c706b31b1a6058e1798e7452 |
|
2015-10-29 12:38:34 |
Hong Kong Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c7c904ea5a36a176eb1b2cb112d8ed3 |
|
2015-10-30 14:08:04 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4ed07c143bc5976f28ff28a16d4ab80 |
Commitments Test Entity - First Quarter Report
|
2015-11-03 13:36:34 |
SUDA Invited To Northern Australia Investment Forum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aad274f68a7b401c1a027136a57d2464 |
|
2015-11-12 14:54:52 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61dcda741445c1d5afc2e074b0516c0e |
Ceasing to be a substantial holder
|
2015-11-17 10:09:52 |
SUDA LTD BUSINESS DEVELOPMENT UPDATE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/876cadc035b2a067f3edf27928028668 |
|
2015-11-17 13:07:05 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f577b0481b2c95f6364ec8f3adf7a38 |
Chairman's Address to Shareholders
|
2015-11-17 15:50:47 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/661535eb5115946d4c8565e4d808e559 |
|
2015-11-24 08:26:56 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d514a61a7ed90e9068292de76c8a344f |
Becoming a substantial holder
|
2015-12-07 14:22:18 |
Response to Price Query Letter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/62466488d31560d5c0da0015e6b6a833 |
|
2015-12-10 10:34:26 |
SUDA amends agreement with Amherst Pharmaceuticals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56884ffaf92dff118848f0bd2edbe465 |
|
2015-12-18 14:47:44 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d8dbfaaca90233b1ff19da98510726c |
|
2015-12-18 14:50:46 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3c18f15012289b4113ad4a4b2e716fc |
Change of Director's Interest Notice
|
2016-01-29 14:57:54 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15bf5d1a4c57bb9c347056f01b815858 |
Commitments Test Entity - Second Quarter Report
|
2016-02-05 10:18:13 |
SUDA receives $0.7m R&D tax incentive refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db57a2524bb39bbdb5604f26c5746c69 |
|
2016-02-08 12:33:28 |
SUDA LTD Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec4712b83e9b21d4bf287d6ba1e1b3db |
|
2016-02-09 13:52:48 |
SUDA Ltd announces new analyst coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b9dabc247a709f0b92b11cbcb9cd3ec |
|
2016-02-11 16:39:32 |
SUDA featured in Business Review Australia |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb723aee9132ee73a83f9254af390fb3 |
|
2016-02-25 10:18:15 |
SUDA Ltd investor presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/872e415a20537837aa041d4f6ccc35f1 |
|
2016-02-26 17:28:26 |
Half Yearly Report and Accounts (including Appendix 4D) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ef4af81c2cd26688b519c63f2b004e2 |
Half Year Directors' Statement
Half Year Directors' Report
|
2016-03-08 12:47:45 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a50a3c158353b9b300c1f4b4fa26182a |
|
2016-04-04 11:36:35 |
Appendix 3B and Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87352fbfe063a790be0cdb4a5ca37b15 |
|
2016-04-12 13:03:58 |
SUDA granted Canadian Patent for SUD-002 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d9c18c28a34abdcf101864f17644e70 |
|
2016-04-19 09:08:05 |
Business development update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2aa2eee930c911c6e637d8ceea6d8b84 |
|
2016-04-28 12:31:30 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d55103eeb00b8fd0fc91fc77fa7ec7b |
Change of Director's Interest Notice
|
2016-04-29 11:19:15 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c30e5c7be625c3a549d0dfb851274e5 |
Commitments Test Entity - Third Quarter Report
|
2016-05-03 10:47:45 |
Investor presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75cefff52f519f0ea2e9709cbc3f363d |
|
2016-06-03 14:53:11 |
Update on HC Berlin Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/897cd3f4b41f05ff73325476add35dbd |
|
2016-06-07 11:41:32 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/949084617ca45fd352816434ff501a75 |
|
2016-06-14 12:38:35 |
Analyst Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/141169475c6830597cc35ef9a1174ad0 |
|
2016-07-29 15:41:38 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e826516e0ec7292cfbcb02208b5ccf7b |
Commitments Test Entity - Fourth Quarter Report
|
2016-08-31 17:13:10 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d875e8249100e860ca145228a6240121 |
|
2016-09-13 09:24:19 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/189032c88d541a7544688c8ace9e670b |
Letter to Shareholders - Other
|
2016-09-20 09:24:21 |
Investor Road Show Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5d2290fa906ae6747afb265c10e27bc |
|
2016-09-22 18:55:51 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/053802abcf97b72123579c1a707a1d8f |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-09-22 18:56:52 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c82133e2755c2341b3735bd79307e8b1 |
|
2016-10-05 14:46:44 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f50557e4d63978a505a93fea5cdaff5 |
|
2016-10-21 13:19:18 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fb17937c572d101e67d07df07ef6abd |
Notice of Annual General Meeting
|
2016-10-31 16:51:50 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d064e4fb87a48ebc4aff415691e5320 |
Commitments Test Entity - First Quarter Report
|
2016-11-01 20:20:19 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f28c104d754f6f94aef3505d3451a1fd |
Ceasing to be a substantial holder
|
2016-11-02 10:36:31 |
Technology patent application |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c7c5e12ad283c0564d42792706299d4 |
|
2016-11-09 08:26:12 |
SUDA Enters Licensing Agreement For ZolpiMist in China |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc00888704408047e51bb934448775c1 |
|
2016-11-17 13:24:18 |
SUDA presents data on novel technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8350ffded491019f596e297630cf2e80 |
|
2016-11-25 13:24:22 |
AGM presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c59f4c89c7d45cad8673d318acc5877 |
Chairman's Address - Other
|
2016-11-25 17:47:46 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84d9bbefd3c7ade516604a58fd1069eb |
|
2016-12-01 12:30:28 |
BRR Audio Webcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4817ad5a241a2b3eb996e69dcc5f66d2 |
|
2017-01-24 13:16:13 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab147eddf0c8b8581f76ddef3314b71a |
|
2017-01-27 09:21:14 |
Suspension from official quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/efac7f9c36770afc90c0276902569692 |
Suspension from Official Quotation
|
2017-02-01 09:32:14 |
Appendix 4C - quarterly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d0a0ea9caae1b726f7e23187f5f1b1f |
Commitments Test Entity - Second Quarter Report
|
2017-02-10 13:56:50 |
Company Update Regarding Suspension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d555b6520f2a354c38a88028fb7a8d5c |
Suspension from Official Quotation
|
2017-02-16 10:09:07 |
SUDA receives $0.9m R&D tax incentive refund |
0 |
https://app.sharelinktechnologies.com/announcement/asx/804c86b94251a130645d9f3b695a79a2 |
|
2017-02-20 14:25:48 |
Company Update Regarding Suspension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d781ed24dd03f2d30c52f879708deb9c |
|
2017-02-27 14:21:11 |
SUDA Update On Discussions with Berlin Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b439113bfcdb3c3cab91a50d5aacb8b |
|
2017-02-27 14:21:16 |
Reinstatement to official quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/68d78e27949c35d241c93ac57387681e |
Reinstatement to Official Quotation
|
2017-02-27 14:50:45 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af1d2ef753519ca4dc7e6388c483df0f |
Half Year Directors' Statement
Half Year Directors' Report
|
2017-02-27 15:17:06 |
SUDA Announces Strong Revenue For Westcoast |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1454b8f47620c00935d68eb41fa700b |
|
2017-03-03 10:29:26 |
SUDA expands patent coverage for SUD-003 and SUD-004 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb95de44e58533782ed90fd9a0c0a975 |
|
2017-03-29 12:23:19 |
SUDA Enters Feasibility Agreement With Pfizer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de9b4a49a0d3db18637245eea46432c2 |
|
2017-04-03 08:15:02 |
SUDA Extends Maturity of Convertible Notes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/394aa260bdf7ecf6e4db48bac9827e99 |
|
2017-04-03 11:19:15 |
SUDA Submits Application For ArTiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b9c7541bc6743164f4cdc0ecd62ac55 |
|
2017-04-05 08:54:49 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc3facade5ee8be96c41e6a281a6d086 |
|
2017-04-06 19:21:13 |
Appendix 3B and Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ef28cf804c38c5eb6afc3364c4f4682 |
|
2017-04-07 09:28:24 |
SUDA Completes $1.5m Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c0e5232447a13af9bf7ba2a3a450bebf |
|
2017-04-19 18:55:52 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7091f893cd06c6d2ef241e8e4fc840f |
Commitments Test Entity - Third Quarter Report
|
2017-04-24 17:11:07 |
Placement, Interest Shares and Convertible Note Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a73626f1cec04a6a3dadb1fb904d2442 |
|
2017-04-27 08:19:47 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9bb2685968827967669b2dd442534b0c |
|
2017-05-23 17:25:24 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7883e6c755cdba5bfc6e91f4b74ddb9 |
Change of Director's Interest Notice
|
2017-05-25 10:55:51 |
SUDA Meeting For Zolpimist Into Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/502dcf1784f995f908f359d92d82471a |
|
2017-06-02 13:59:58 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5851e6cef696041d99fd956b0f4997a8 |
|
2017-06-07 13:30:29 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c312ecd2a94422e644b8e71f1b66c516 |
Change of Director's Interest Notice
|
2017-06-20 11:29:27 |
SUDA Signs Term Sheet To Acquire Anti-Cancer Agent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1271938d4f4368a2d48f734ca5ce3be7 |
|
2017-07-04 09:20:14 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2d1b4e29e9f506ed9c98b03e2792c6c |
|
2017-07-05 09:17:58 |
SUDA Enters Licence Agreement With Teva |
1 |
https://app.sharelinktechnologies.com/announcement/asx/661f708e74b6b9660e4086050bebc2fc |
|
2017-07-06 11:52:50 |
SUDA Announces New Flash Note |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51e1abe11a144cb1857dbb874bd2a59d |
|
2017-07-24 08:24:12 |
Strong Revenue Growth for SUDA Subsidiary |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4fd21a597a878cad0c220070b6652689 |
|
2017-07-27 11:46:43 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10dbd1c0b3feccfdcb85f6756d7eab47 |
Commitments Test Entity - Fourth Quarter Report
|
2017-07-31 08:16:05 |
SUDA Achieves ISO Accreditation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/241b786d08e50199d12b48d16b95b03e |
|
2017-08-15 09:22:20 |
New analyst report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c56a8390aa663414e75f3569cd0d204 |
|
2017-08-15 12:28:25 |
Investor presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2929b0aef42d5e824d13af4621f2889 |
|
2017-08-23 14:26:23 |
SUDA announces new media article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7e605dd30321cacaeb40e768a8bb3ad |
|
2017-08-28 14:22:20 |
Chairman's letter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c585434bb7c5222af05df88f38c8fa8 |
|
2017-08-31 13:10:08 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a9c78c590f38eb46ab2f756954b862a |
|
2017-09-12 11:46:35 |
SUDA Publishes Amended Shareholder Newsletter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0380901c038dd6ef16a88d231d2b6f01 |
|
2017-09-22 18:41:37 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c8f4ad12b1a875784b61ee9a6547194 |
|
2017-09-22 18:42:38 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b34b3a73657bc727fb6a09ee3ee62649 |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-10-06 08:26:42 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df17439d113c40a88d86737d9aad9eac |
|
2017-10-30 17:50:48 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d10eecdfd359099e81dd5a78f1945d5b |
Notice of Annual General Meeting
|
2017-10-31 13:43:41 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/744e81d27a1a452472b49bcd530bc474 |
Commitments Test Entity - First Quarter Report
|
2017-11-03 12:32:31 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d645b96337962ad9aa038d6f9ef92cd |
Change of Director's Interest Notice
|
2017-11-09 08:26:04 |
SUDA Announces New Media Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd5a394147c7638075db499c64b74360 |
|
2017-11-10 13:32:31 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95538d15efc2b568f7c76a4b6387eaed |
Change of Director's Interest Notice
|
2017-11-17 12:15:14 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/005b762e1e67dbbea84e4b4775986bae |
Change of Director's Interest Notice
|
2017-11-24 08:20:57 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90bfec122e9ad6d438b42a4e66843b2a |
Change of Director's Interest Notice
|
2017-11-28 08:25:37 |
SUDA Acquires Novel Oro-Mucosal Anti-Cancer Agent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/acd939a06253060cf771fcba466cef34 |
|
2017-11-28 13:11:09 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/faf2c171ad1b7dd8361f89dd6cfdde6f |
Chairman's Address to Shareholders
|
2017-11-28 17:40:33 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b894ad0dbd19502627b195193f0aa48c |
|
2017-11-28 17:58:51 |
SUDA Appoints David Phillips As Advisor To The Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dcddc8bc781764c8637e03d0854d291 |
Company Administration - Other
|
2017-11-29 13:20:19 |
Change of Company Name |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc8a2ce074707f5e7c9d7659cad94a68 |
Company Administration - Other
|
2017-11-30 08:22:41 |
SUDA Receives R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3dfdb030ac252c006ede01f36d169097 |
|
2017-11-30 16:37:35 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/294ba8267cb8e06209e67b5767e2b0cf |
Change of Director's Interest Notice
|
2017-12-06 08:26:11 |
SUDA's Licensee Submits Marketing Application |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22c6ba3236347945611271ef8482839f |
|
2017-12-12 14:24:22 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f980f59f2c109bdb03479b6007b4502f |
|
2017-12-12 14:28:26 |
Change of Directors' Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bafe8ee741cc13487133a81d6e60978 |
Change of Director's Interest Notice
|
2017-12-12 15:10:09 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3ad0723d4ad2da9d732106aae482762 |
|
2017-12-13 08:20:08 |
New Data Supporting Use Of Anagrelide To Treat Cancer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/959b5db7c68f1f4276bec29fb24c9b13 |
|
2018-01-24 08:33:54 |
SUDA Completes Acquisition Of Anti-Cancer Agent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aeb87420ea1e42c1e572e1bf7ecc58ed |
|
2018-01-31 19:24:23 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/111cf1b290d596e304f12cfe00fda328 |
Commitments Test Entity - Second Quarter Report
|
2018-02-16 10:08:04 |
New Analyst Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/773c666c075a9ae0ee08ed7ba8a28c9f |
|
2018-02-27 08:13:32 |
Divestment Of Non-Core Subsidiary |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ca7a3f8521ecc3a79ecbeaa552ccd49 |
|
2018-02-28 18:17:14 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aecdddc3d47b0528e71851c39a124a68 |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-03-08 08:25:53 |
SUDA Completes Divestment of Subsidiary |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee083d59ff9eb86660048e18d7c165c8 |
|
2018-03-29 15:18:04 |
HC Berlin Pharma Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e876d98dcfa7cc0701d6811da362a680 |
|
2018-04-05 15:32:30 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c66ba3cee92baa8eb0d9b63072f9e4f9 |
|
2018-04-09 08:58:56 |
SUDA Appoints David Phillips To The Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/355bd6636cf09b49fb1ae0eb6a31c27e |
Director Appointment/Resignation
|
2018-04-09 16:16:14 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7466c35d0603eb2aaab966cdc95e5932 |
Initial Director's Interest Notice
|
2018-04-10 13:05:03 |
SUDA Announces Resignation of Michael Stewart |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20458fa61a359872304033a7c92779ff |
Director Appointment/Resignation
|
2018-04-11 16:39:38 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/756055998a75f18b488c1118b45dc1ff |
Final Director's Interest Notice
|
2018-04-30 17:04:03 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef19fe6eba66e9d3c100fdafddf819d0 |
Commitments Test Entity - Third Quarter Report
|
2018-05-01 11:21:14 |
HC Berlin Pharma Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78519d10a8132a5f17195e36286154f1 |
|
2018-05-04 14:40:36 |
HC Berlin Pharma Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07b34f795c487db589f7c1fffadd8b5f |
|
2018-05-07 12:31:26 |
SUDA expands dialogue with World Health Organisation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdb630a1201edb22989d274f06c56e8c |
|
2018-05-09 09:06:02 |
Shareholder update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04b4b71bb3041919c41a36101d002ec2 |
Letter to Shareholders - Other
|
2018-05-15 09:06:04 |
SUDA Establishes Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e3e9a234fcf9c4a2aa7ffe0656542f8 |
|
2018-06-15 11:18:14 |
SUDA announces update on ZolpiMist in USA and Canada |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb41a41e45648a9907fb9b75658bbbad |
|
2018-06-18 09:03:00 |
SUDA Expands Patent Coverage For Sildenafil |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a10dfd76069d8474801570b15b2698c2 |
|
2018-06-21 08:26:28 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea7177d3569a70c18174d80640e6d847 |
|
2018-06-28 09:14:09 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/88f60463163418afca6ac9d14224c9e8 |
|
2018-07-02 09:37:32 |
Settlement with HC Berlin Pharma and Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f673f42f29b4c426640ca475a4b1795 |
|
2018-07-02 09:37:35 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9238901a4d006779ebd0e9414231cc4 |
|
2018-07-02 09:37:41 |
Prospectus for a Renounceable Pro Rata Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/137942280f0684638fb5af3da18b4be3 |
|
2018-07-02 09:37:42 |
Letter to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/611fa4969edbc00f992dd467241765ce |
|
2018-07-02 09:37:43 |
Letter to Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8351dc0e1bd4df03674acef4c6edd03 |
|
2018-07-12 09:28:26 |
Anagrelide Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1814436652a73e1f827f4d37a481bcef |
|
2018-07-16 08:23:11 |
Business Development Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a49ae106bb4ba94adc10e0cc1cbb36b3 |
|
2018-07-16 12:51:46 |
ASX Waiver To Grant Secured Convertible Notes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8bcd54f7b0967724d9333c020efb8b5 |
|
2018-07-17 08:23:45 |
Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e80d24430885d33cd894fdcbed64a967 |
|
2018-07-25 08:18:15 |
David Phillips To Lead Business Development |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eff4f98e4b3746d736e2bb94f08ee9b4 |
Company Administration - Other
|
2018-07-31 18:18:16 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1226968b03f28fd8388165d9d1aa7524 |
Change of Director's Interest Notice
|
2018-07-31 18:20:18 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3316cf28fa1d7c9c684b88dcfb6f2bf1 |
Commitments Test Entity - Fourth Quarter Report
|
2018-07-31 18:25:21 |
Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c22e8d442b4a1afc057c6d4a2356cd0 |
|
2018-07-31 18:27:23 |
Rights Issue Closes Significantly Oversubscribed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1bb9b8fda0d313f1246958595e79ca18 |
|
2018-08-02 12:00:59 |
Rights Issue and Placement Completed and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/282460ffe4bd00bf222f44759d1e3211 |
|
2018-08-03 11:16:14 |
Change of Directors' Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee48b0daaf05ed19afa794f10cf29020 |
Change of Director's Interest Notice
|
2018-08-14 13:12:09 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f0970404503e2687af975a1d7446524 |
|
2018-08-21 08:24:37 |
SUDA Achieves TGA GMP Licence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/36b1d1e8922c30f36e1cf22075c02ead |
|
2018-08-22 08:20:14 |
SUDA Expands Patent Coverage For Sildenafil Sprays |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1913893f3c9a9d0453cbf78fdb4ae75 |
|
2018-08-28 11:16:06 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3c10aa95b1250b0c905af244b1cb78b |
|
2018-08-31 15:41:39 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/28895744cef1dfad23d6c953f02df764 |
|
2018-09-06 08:33:02 |
SUDA Expands Scientific Advisory Board For Anagrelide |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0e7edf8847398eafe869b378e770fb7 |
Company Administration - Other
|
2018-09-10 08:36:01 |
SUDA Accredited As An Australian Trusted Trader |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdfbf744e324a73517333ace571de162 |
Company Administration - Other
|
2018-09-11 09:48:44 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07be363c61f38fe525a2c8d3d8b38939 |
|
2018-09-11 11:43:40 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a2f2f55adbbc97a74ae8cea147da933 |
|
2018-09-11 18:00:54 |
Request for Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/004ae9cde60ac474980a3a19db83c571 |
|
2018-09-12 10:00:55 |
Market Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/93a4c2d4137426642115fc1fcb232f5a |
Company Administration - Other
|
2018-09-28 19:29:26 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27129680f706243714f3b3a9c3c418b8 |
|
2018-09-28 19:32:28 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96912129c73233252ee96f1031389178 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-10-11 08:30:08 |
SUDA Appoints Business Development VP In The USA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea5a2af77d66a1ef9257f4596be968f7 |
Company Administration - Other
|
2018-10-12 12:27:25 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/346e90090847ebfbf6b5022d60cf0b58 |
Notice of Annual General Meeting
|
2018-10-17 10:47:46 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44d287e324b1c1a22752d6f76ce1b314 |
|
2018-10-17 11:12:09 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be4a395873c24e40f12f78bdffba7ce6 |
Suspension from Official Quotation
|
2018-10-17 14:08:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2c183db477350211e2f4a34e720fefec |
|
2018-10-17 14:08:03 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/367b01b1ec2b784751d63af1e5440414 |
Reinstatement to Official Quotation
|
2018-10-29 08:28:05 |
Appendix 4C, Market Update and Top 20 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab1ec2fdef7a8957cc421a173a406230 |
Commitments Test Entity - First Quarter Report
|
2018-11-07 09:10:07 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7f61447882b836022c663cfba24d408 |
|
2018-11-08 09:43:35 |
SUDA Signs Agreement For SUD-001H For US Market |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4845104025b37cdbd20d7743e205b071 |
|
2018-11-08 12:34:32 |
Boardroom Radio Broadcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7cebeaf27a6f7022fd40f982f3ccf4b2 |
|
2018-11-09 14:50:47 |
Strides Press Release |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c25d00d65ebbb71a3d784a7666b6cb1 |
|
2018-11-12 13:54:50 |
Anagrelide Paper By SUDA Scientific Board Member |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2061b495d559ffcfbc9c1cc90dfe7913 |
|
2018-11-13 09:44:40 |
ZolpiMist Market Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3236327edcb2f6d04138cedc36559a05 |
|
2018-11-15 08:23:19 |
SUDA Receives R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fbe1f7ae3f1dc9f34d5db767581a4ab |
|
2018-11-15 12:58:56 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/945d1bdc0a8c92823f71c29c54cdf5a3 |
Chairman's Address to Shareholders
|
2018-11-15 15:58:57 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8705e8de9ccf48faaa7f4b9e5b6c6238 |
|
2018-12-06 08:24:19 |
SUDA Enters Agreement To Develop Cannabinoid Spray |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d6491a130928b0d67ee94905aa47e72 |
|
2018-12-06 08:53:50 |
ZLD to Invest in Development of Oral Spray Formulations |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d06332f07e22a39d1380c9bffce94c3 |
|
2018-12-19 08:23:26 |
SUDA Signs Agreement With Mitsubishi Tanabe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66ecff2f3f10a95c671df1a947b76593 |
|
2019-01-31 08:25:18 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b36f3bd94ac11bb733e81ee6f70fe9dd |
Commitments Test Entity - Second Quarter Report
|
2019-02-04 17:04:01 |
Appendix 4C Amended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f9d2aad934f5d81a4c122137aba03a9 |
Commitments Test Entity - Second Quarter Report
|
2019-02-04 18:22:19 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e1d99142c23c5e90cf8ce2e0336d00a |
|
2019-02-18 13:06:02 |
SUDA Continues To Expand Patent Coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29600d5229e8bb20595de2532cb7d17d |
|
2019-02-21 08:24:23 |
Program Update Anagrelide |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7679256b60fbc665f9ef42fbc020a405 |
|
2019-02-28 19:16:05 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/243f9f45367549f43d9b6f00420b5301 |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-03-01 17:18:16 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27c91bc2df5438d42ec088038fab2caf |
|
2019-03-15 08:23:48 |
Program Update Anagrelide |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ff9ed7bb36da3d95e7b565c47c751c8 |
|
2019-03-27 08:29:22 |
SUDA Appoints David Simmonds To The Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b38ceaa0065775431774e4d964213d77 |
Director Appointment/Resignation
|
2019-03-28 12:49:48 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6357af8166ce6175ed506d909b8dd048 |
Initial Director's Interest Notice
|
2019-04-04 08:22:15 |
SUDA Submits MAA For ZolpiMist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ec17857feac1809c7ad60ab4228d8a3 |
|
2019-04-18 09:09:06 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2124b2121b47d55e122d4c01a85501e8 |
|
2019-04-18 15:43:30 |
ArTiMist Regulatory Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7ba21b40d0ab0e10f42912feaa661d4 |
|
2019-04-30 13:35:30 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fbcc4f07753aa8c9660f6982a379ee1 |
Commitments Test Entity - Third Quarter Report
|
2019-05-13 09:17:08 |
Product Development Market Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8dfda70d6866b2d940c23985a7639583 |
|
2019-05-15 08:29:22 |
Paul Hopper Appointed Chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34e6770a3498ca03b9362884f7d3af4c |
Director Appointment/Resignation
Company Administration - Other
|
2019-05-17 08:23:24 |
SUDA Restructures Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4e56dfea20d98ae5b85a8300482d437 |
Director Appointment/Resignation
|
2019-05-17 12:19:17 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f57917b4f83bef7fff6298dfa0c2db2f |
Initial Director's Interest Notice
|
2019-05-17 17:03:01 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4552a4f1ae43f52adce845825968dbde |
Final Director's Interest Notice
|
2019-05-20 13:56:53 |
Overview of David Phillips |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0949dd1a89decbc85eeb8520509b01e3 |
Company Administration - Other
|
2019-05-27 08:32:15 |
Media Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abcdb03b11e0c8f347d0fa34fcc24d05 |
|
2019-05-31 12:09:06 |
SUDA Launches New Website |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d97ea522fb6aa2e9bb71a2f0c1f951e4 |
Company Administration - Other
|
2019-06-03 09:03:00 |
Rights Issue To Raise Up To $3.44 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d812bb6ec08caa66eb29169d5bd7a30f |
|
2019-06-03 09:06:03 |
Prospectus For Renounceable Pro Rata Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/437287af5215d3098b545abdfb906dee |
|
2019-06-03 09:08:05 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86a1994e19e4bcbe23514c00c866068a |
|
2019-06-03 09:09:07 |
Letter To Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a3814c715054d0bb8352c9072e7ea0b |
|
2019-06-03 09:10:08 |
Letter To Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff6c1aca3b60a94ea7c6fd1010fb28a7 |
|
2019-06-03 09:11:09 |
Letter To Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e710e879b833c7436de4f7beb1d05c16 |
Letter to Shareholders - Other
|
2019-06-04 12:17:15 |
Corporate Presentation June 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63f2f82645cdaf027fdf716a71ef7e68 |
|
2019-06-04 12:47:42 |
SUDA Expands Business Development Team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efb713a978a5951fc83814dc8d17502e |
Company Administration - Other
|
2019-06-05 09:28:25 |
SUDA SIgns Binding Term Sheet With Cann Pharmaceutical |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e62013cc6485fc2782763433fbe2c446 |
|
2019-06-05 13:09:06 |
Rights Commence Trading |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fa52ae786264fe757bfe3509d7a79fc |
|
2019-06-26 08:20:12 |
Rights Issue Closes Significantly Oversubscribed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f328b3b0a282ba7b972c8d18f564b5a7 |
|
2019-06-27 16:15:08 |
Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab70bcba5d3a5b0a034ab70bc92b0ab3 |
|
2019-06-28 12:09:06 |
Rights Issue and Placement Completed and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef23ba64912448da2aa3d502a18ee6fb |
|
2019-06-28 12:32:29 |
Change of Director's Interest Notice (x2) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93fb78a36a291dd18bd7e7a7afc79fb5 |
Change of Director's Interest Notice
|
2019-07-03 14:19:17 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/114f923824f5e844a8ee59c13d531389 |
|
2019-07-10 12:09:07 |
Top 20 Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0ce7f584772db8744a88bc2c08c7e6a |
|
2019-07-18 08:28:20 |
ArTiMist Regulatory Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a61a986abcc10592c27cca3a40b79a7 |
|
2019-07-22 08:19:22 |
European Anagrelide Cancer Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7303c12bfa3278bf62dde520ba5b8936 |
|
2019-07-25 08:25:01 |
Operational Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58645fc9a4844bdd98a2582346d45abb |
|
2019-07-31 12:07:05 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f6c4c0f92e7faae64bae1a4c8d0ad3b |
Commitments Test Entity - Fourth Quarter Report
|
2019-08-06 12:27:25 |
ZolpiMist Clinical Results Published |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c128b306ffb2f9650805881784a83e06 |
|
2019-08-07 08:20:01 |
Government Initiatives To Boost Medical Marijuana Industry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/943623cb6956bd228dd1a8fbc6da6afe |
|
2019-08-09 09:09:04 |
ArTiMist Appeal Lodged With TGA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8620b6bb96ba86ecd515e0fc0231cf0c |
|
2019-08-14 08:17:04 |
New Project Director For Anagrelide Project |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e6f0c131588a4f98574646bfbf667a7 |
Company Administration - Other
|
2019-08-27 11:58:55 |
Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e25b39e8a49bf29548e3f94c38b0c8d |
|
2019-08-29 13:06:58 |
Article on Anagrelide |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7026cf43697f8a9f3fb08415b1396453 |
|
2019-08-30 08:10:58 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/096aadb8d9e5710b3408213a9f9fd248 |
|
2019-09-11 12:57:55 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c30483e9c2a06e0f15af78f77d873cb |
Change of Director's Interest Notice
|
2019-09-24 08:19:07 |
Manaing Director and CEO Resignation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ed429c3e3c35211fa9439d108485796 |
Director Appointment/Resignation
|
2019-09-24 13:28:26 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2974a4481511fc73461b7b6ea80b0c64 |
Final Director's Interest Notice
|
2019-09-24 19:19:12 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/322ecc0cd91dae5f60718f447fadeb31 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-09-24 19:19:14 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/435bff147085166fca1dafc752000b3d |
|
2019-10-01 08:31:23 |
TGA Declines ArTiMist Appeal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7eaa6b015555462ca0198d5e880fc76 |
|
2019-10-02 16:47:44 |
Response to ASX Query regarding Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cfc1782b94c00d36f7c8e064a2a8ef26 |
|
2019-10-04 08:21:09 |
ArTiMist Appeal Reasons For Decision |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5f01e275bcc37318671e8c76c513517 |
|
2019-10-14 13:30:27 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8cb8b6fef9164b68114b80b103b4e8c |
Notice of Annual General Meeting
|
2019-10-14 13:42:38 |
Proposed Share Consolidation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40be12e225da7b2456e1cb4d90cafad4 |
|
2019-10-30 08:14:58 |
SUDA Finalises Agreement With Cann Pharmaceutical |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dce1b6379fc3bd9e54e79655886af9db |
|
2019-10-31 08:12:11 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e7493d0314b5dc5febde81a578b3930c |
Commitments Test Entity - First Quarter Report
|
2019-11-04 08:15:24 |
Case For Share Consolidation and Appendix 3A.3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d651875c0352959a358b4e24d08b1ae |
|
2019-11-06 13:47:45 |
Consolidation/Split - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b9aa19c25bc88da2473b3a872a64bb3 |
Alteration to issued capital
|
2019-11-08 08:22:03 |
SUDA Management Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/193eb4de514a5b55bfde7c752078795e |
Company Administration - Other
|
2019-11-12 13:23:19 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fd1c83b0eea7107db7ac114f2bd1b6f |
|
2019-11-12 16:41:39 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8748759454e77067af5ca2737fbc572 |
|
2019-11-12 19:17:12 |
Update - Consolidation/Split - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59d67e76db24c6b6f04f5fce910a4089 |
Alteration to issued capital
|
2019-11-18 08:15:45 |
SUDA Receives R&D Tax Incentive Refund |
0 |
https://app.sharelinktechnologies.com/announcement/asx/939a6572b2940c53d2012525889e0852 |
|
2019-11-22 14:17:14 |
Completion of Share Consolidation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89641019929c71480d573cb6505194f0 |
Alteration to issued capital
|
2019-11-25 13:42:40 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5319649a70bae713cdc497f4e2c90327 |
Change of Director's Interest Notice
|
2019-11-27 09:37:34 |
SUDA Appoints Dr Michael Baker CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7e2ef641c5df3d4e14482d0a96dae3f |
Company Administration - Other
|
2019-12-05 08:23:28 |
SUDA Signs Co-Development Deal With Ordesa |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f18558f4933cd2377f58ebe7cbd7b66f |
|
2019-12-09 08:19:58 |
SANOFI and SUDA Entered Into A Feasibility Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/676af63ecf37eee71a63eb64aa144f9d |
|
2019-12-27 17:25:21 |
Australian Public Assessment Report For ArTiMist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee319cd65d04aafd5b2ee61b841b202e |
|
2020-01-06 16:14:12 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f23543c65dc4c1344e0ff6a4e9ea6bc |
|
2020-01-06 16:19:17 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f206a3f1d041afa5d7fcfc46e38d8f89 |
Change of Director's Interest Notice
|
2020-01-08 12:53:51 |
Interview With Michael Baker |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc2b8449157e280e5e9484ab31f11b47 |
|
2020-01-20 12:17:14 |
Newsletter January 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b9eec0f77d452403bdc6d7444101acb |
|
2020-01-23 14:45:41 |
Interviews With Michael Baker |
0 |
https://app.sharelinktechnologies.com/announcement/asx/620150be7744671bbcd097246a9c7aa9 |
|
2020-01-31 12:29:26 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/69a6007f219c5d47ca467223b7a8caa4 |
Commitments Test Entity - Second Quarter Report
|
2020-02-26 13:56:54 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/579f9f06ef1e9621b45cebfc3bda2cf9 |
|
2020-02-26 18:28:24 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/18a2ccd6521b7c886fc6e49e0b872476 |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-03-11 08:17:04 |
Interview With Michael Baker |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56480538952c491fc8204b561a9177d7 |
Company Administration - Other
|
2020-03-23 09:35:33 |
SUDA Signs Additional Licence With Mitsubishi Tanabe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43df610c619d233e90db8dad6b1e2b4b |
|
2020-03-30 14:04:00 |
ArTiMist Program On Hold |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d98c44561b754ca39365757ad565af94 |
|
2020-03-31 10:40:37 |
Letter To Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71a57f3c808c45efa0289ab67ac99d1b |
|
2020-04-30 10:54:52 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/622cbd8c9f17b47e6c1a4556ec6bc53a |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-05-12 08:19:23 |
ZolpiMist Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c27705f3a749b444297a1780de0bcdf |
|
2020-05-20 10:16:11 |
Anagrelide Cancer Patent For Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd873c2874891f7106eb714d3dc5edd6 |
|
2020-05-27 09:08:04 |
Anagrelide Project Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c63629748ad2918691027a94051f54f8 |
|
2020-06-01 10:11:10 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c1ecb868eb1844ac94574f95c1ef24fe |
|
2020-06-01 10:20:16 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b991e7bd863669ba75b7973b8e1af99 |
|
2020-06-05 09:10:06 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f6562fb16716d99058833e5a3e4708e |
Suspension from Official Quotation
|
2020-06-25 09:37:24 |
Market Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3c1c895aec18ebd549881e9bf340e8ca |
|
2020-06-25 09:37:31 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b7eed1ab807adb2e84b98face09015c |
Reinstatement to Official Quotation
|
2020-06-29 12:08:06 |
SUDA Appoints Dr Baker As Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb4210d20564a881f20dbf27aa12d5ad |
Director Appointment/Resignation
|
2020-07-01 12:41:37 |
Joint Company Secretary and Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4fae10ff7a3bd9b7daa0e897b4e2eaa |
Details of Registered office address
Company Secretary Appointment/Resignation
|
2020-07-03 08:54:51 |
Entitlement Offer To Raise Approximately $3.56 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d2d12deaf374dcc186e5e0e0341a5c2 |
|
2020-07-03 08:58:55 |
Prospectus For Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1df90daa1e0452fec60445a1739a21ba |
|
2020-07-03 09:00:59 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5689f061a2f165036ec184e52442bde7 |
|
2020-07-03 09:03:01 |
Notice To Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07ed729c21daeaf6e550a58b44b8e6a6 |
|
2020-07-03 09:04:02 |
Notice To Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25806867231c97318cfc2af9c8a64816 |
|
2020-07-03 09:05:03 |
Notice To Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fed86ed0340fcee8b743a60adacdbb03 |
|
2020-07-03 09:07:05 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95a45d29eec8469d6b62631e77e5bbba |
|
2020-07-03 14:13:10 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c555b2bc1990dc1728325db47ab1f18b |
Initial Director's Interest Notice
|
2020-07-16 11:25:17 |
Extension Of Offer Closing Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9396e85544577e03be2519348504b1d5 |
|
2020-07-16 11:31:29 |
Update - Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d11c7c9186c17b0ec3b318883ab0c2bc |
|
2020-07-29 08:19:10 |
TGA Approval Granted For ZolpiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f726e32fd7126c78c2e605159066ce73 |
|
2020-07-31 12:45:41 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9f69502b23195899e214ec55520c1ab |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2020-08-03 10:13:07 |
Entitlement Offer Closes Significantly Oversubscribed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19dddee77856beb41f10c65deb12d1eb |
|
2020-08-03 13:59:57 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4330883987ee7cd0cbb06cc05314c853 |
Becoming a substantial holder
|
2020-08-03 18:19:17 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98b7674710633899a74a9473ddcbc133 |
|
2020-08-05 11:51:48 |
Entitlement Offer Completed and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb801c9eab4e1e2ced1023d0014ca68b |
Appendix 2A (Application for Quotation of Securities
|
2020-08-05 12:10:08 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b157f0c663ca450dd8b4e05355435b4c |
Ceasing to be a substantial holder
|
2020-08-05 12:43:40 |
Top 20 securityholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/278ef6c8c59ca8f8a155a4eec69c2682 |
|
2020-08-05 13:30:27 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9251b2e194e359a535f18f0126971dc4 |
|
2020-08-05 17:30:27 |
Distribution of Security Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed703a419bd4c452ea56f002a0aba069 |
|
2020-08-07 10:37:34 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6de7f9c4e62cd47af1073eb839de35c |
Change of Director's Interest Notice
|
2020-08-10 18:28:22 |
Placement Offer Completed and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c40876759c04311542f6080b4f57449f |
Appendix 2A (Application for Quotation of Securities
|
2020-08-18 13:27:24 |
Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b28d667c3abf6163be98917c2d506f3 |
Company Secretary Appointment/Resignation
|
2020-08-31 09:04:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d97cf55d131bccd1167ceef3ecd7ddb7 |
|
2020-09-08 09:40:38 |
Anagrelide Cancer Patent For Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2fbba501fd34db3b4af285c6ac378895 |
|
2020-09-22 08:50:48 |
Anagrelide Project Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/09e5681ec504a23d40225407787e4c6e |
|
2020-09-25 17:22:18 |
FY20 Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0cd185b4438f1525b7e75fdc4e1d881 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-09-25 17:25:22 |
Appendix 4G and FY20 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3945436f2d9eafaa524938d2a99ae122 |
|
2020-10-08 08:20:50 |
Newsletter October 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b311dde034572901f03f2f120f2a456d |
Company Administration - Other
|
2020-10-08 08:28:27 |
Notice of 2020 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/872e5178858da337131fa5a95d7a524f |
Notice of Meeting - Other
|
2020-10-16 16:48:45 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a3641a85c33b70662716c713273eb28 |
|
2020-10-16 18:07:03 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d387ee00c32c6a19581089c6bf31423 |
Appendix 2A (Application for Quotation of Securities
|
2020-10-26 08:17:05 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a2c1c71c7e1a1da19e330768e3e865b |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-10-27 09:33:30 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2921a265fcf07ad07ace8bf1d5291a8 |
Notice of Annual General Meeting
|
2020-10-28 08:24:10 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/872e21305c1b3cfbbc7001c164c781f5 |
Change of Director's Interest Notice
|
2020-11-09 15:18:17 |
Change of Director's Interest Notice - D.Simmonds |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5c11e1a8e224e1906f64629d7858e31 |
Change of Director's Interest Notice
|
2020-11-11 16:13:11 |
Change of Director's Interest Notice - P. Hopper |
0 |
https://app.sharelinktechnologies.com/announcement/asx/643b2dba0e07aa88ea04b76fa31b1551 |
Change of Director's Interest Notice
|
2020-11-17 08:18:48 |
Investor Presentation November 2020 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7cf1ec1b303f253ddfebcf1842f51fbd |
|
2020-11-24 08:22:33 |
R & D Tax Incentive refund received |
1 |
https://app.sharelinktechnologies.com/announcement/asx/26e89902a5a35620898b388da85ee49b |
|
2020-11-26 08:24:57 |
AGM FY20 Chairman's address and virtual meeting guide |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2efbdfe044ee39044763d13888538ee0 |
Chairman's Address to Shareholders
|
2020-11-26 08:24:59 |
AGM FY20 Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8c231066806ee8f75744aa5e90d2b66 |
Chairman's Address to Shareholders
|
2020-11-26 15:55:54 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e0b040f0adacb31fd4ef0c470ed9e28 |
|
2020-11-26 15:58:56 |
SUD Constitution (amended) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90375328b80a078a919129356546eb05 |
|
2020-12-14 09:35:31 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d9feab9be7618bfd4927321dc6acf135 |
|
2020-12-16 10:24:01 |
Prospectus - Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1a3c004d1d0c27295dd5960b3c3783f |
|
2020-12-16 10:24:55 |
Ordesa Feasibility Study Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/555cacd33a31434f935ebf7da4ffe544 |
|
2020-12-16 10:24:58 |
Placement Offer to raise $2.76m |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05945a6fe97a36c5a8dd2601f4a9b920 |
|
2020-12-16 10:25:14 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2a482c76513b3185c609ca0637c4ddb |
|
2020-12-16 10:25:35 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/284d67aecc1b966493043c04c1238e7b |
|
2020-12-22 08:16:08 |
Company Update - Letter to Shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5f5d82231945d4ded46fcc0a49988b1f |
|
2020-12-22 08:18:52 |
Proposed issue of Securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0fc0036b4fa46e78381d44e77fc70ea |
|
2020-12-22 11:03:01 |
Placement Offer Completed and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f62dd7944685a799aa381ceb9e2ed08f |
Appendix 2A (Application for Quotation of Securities
|
2020-12-24 08:23:37 |
Notice of EGM and Proxy form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64c706a2c28f20ce5d4e935d48ccd594 |
Notice of Extraordinary General Meeting
|
2021-01-18 08:29:06 |
Suda Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b0d9f33206abde362c2efd1d2281cde |
Company Administration - Other
|
2021-01-25 08:21:25 |
Zolpimist Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cee24ae2eafeacebb9f5ad8cf8202485 |
|
2021-01-25 08:40:37 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/572b85df21d344125a638c6ad1b5f894 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-01-29 09:12:08 |
GM presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a953f28ef3d33ea94962b45283fca9a |
Chairman's Address - Other
|
2021-01-29 15:32:30 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/459e0a4ae958ba7c201b55108720bae6 |
|
2021-02-16 08:19:01 |
Zelira Therapeutics Feasibility Study Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b6107f6315c2ea6b9d75801630cdadf |
|
2021-02-16 12:15:11 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67b48fe91acce157e285e7bd540c19a9 |
Appendix 2A (Application for Quotation of Securities
|
2021-02-16 16:38:35 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72679398688b22f3903c3d98b40d9aba |
Change of Director's Interest Notice
|
2021-02-16 16:40:36 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09f2bbda7088e47f60177fc47a1f263c |
Change of Director's Interest Notice
|
2021-02-16 16:42:38 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5d31bcc949bb231c38127b7c57f6cdd |
Change of Director's Interest Notice
|
2021-02-26 07:59:32 |
Appendix 4D & Interim Financial Half Year Report FY2021 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/406703e51f046792bd3c1104e1be387b |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-02-26 08:46:39 |
Anagrelide Project Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aee76462b527cae7c9bbe76ce37a2929 |
|
2021-03-03 16:43:37 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e14536175eadbb8610bd5ab9e260add9 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-03-29 08:25:54 |
Anagrelide Project Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc9538f658c8b6c235b19e3934a17c7d |
Company Administration - Other
|
2021-03-29 11:34:23 |
Newsletter March 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/493745736156a138e672be1fbbeae7a6 |
Company Administration - Other
|
2021-03-30 09:01:57 |
Investor Presentation March 2021 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3967c42b98723595c9a93787428116e7 |
|
2021-04-07 08:23:44 |
Anagrelide Project Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07e60b772a0d40f39e908fb12a5ee406 |
Company Administration - Other
|
2021-04-27 08:21:00 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e150d3fb3930616587f019eb476ad94d |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-06-18 09:26:24 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14c514715cef61de839b61da45ddc0c6 |
|
2021-06-18 10:03:57 |
SUDA Licenses a Novel iNKT Cell Therapy Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a96b825975427f8b91a82762994f646 |
|
2021-06-18 12:37:35 |
Investor Presentation incorporating iNKT Cell Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/19d81f35724df831238a73b5d1876300 |
|
2021-06-18 13:36:25 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63045008f843d285d1c617f0d29a280a |
|
2021-06-22 10:10:04 |
SUDA Placement Raises $3.65m |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b5d4336aeaba453e9adec6bd1d3cb74 |
|
2021-06-22 10:10:04 |
Proposed issue of securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edb3016f64ca4e1b5459e1057861992c |
|
2021-06-22 10:10:20 |
Disclosure Document Prospectus $3.65m |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7b23c1c617ac3c3e8fce995f5be10ef |
|
2021-06-22 16:10:02 |
Proposed issue of securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bde31445d9db669b324b948c1e51079 |
|
2021-06-29 16:31:29 |
Application for quotation of securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6fcb519eea9f4bd606290220bb60d5c |
Appendix 2A (Application for Quotation of Securities
|
2021-07-13 17:54:46 |
Notification regarding unquoted securities - SUD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6226823cfeb4306b30e963df78f2e8a5 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-07-26 10:13:10 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc5fee0197098179d1e68fe42c80b949 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-07-29 09:52:49 |
SUDA to present at NWR Virtual Investor Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5356f9cf25178cbf957003396c34affa |
|
2021-08-02 08:53:49 |
SUDA appoints new cell and gene therapy manufacturing expert |
1 |
https://app.sharelinktechnologies.com/announcement/asx/485df7ae050af503ca14c3385f27497f |
|
2021-08-10 08:18:02 |
Appointment of Dr Debora Barton as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bf96b2b50efc16318ae3f1ca2fc50a9 |
Director Appointment/Resignation
|
2021-08-12 09:47:46 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82a6736dc265ea453301afdebe35f5ab |
Initial Director's Interest Notice
|
2021-08-16 09:54:52 |
iNKT cell therapy platform update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a94205a346625432e7618187bfaaa2c |
|
2021-08-23 15:33:31 |
ZolpiMist Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a7b059779e9589a5dd5bd4b00644585 |
|
2021-08-24 10:43:40 |
SUDA signs Licence and Distribution Agreement with STADA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/301706761df7314735489ac413d71914 |
|
2021-08-26 09:38:35 |
Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3987b542166f6b15d99ebc64eb7ed31d |
Company Administration - Other
|
2021-08-31 10:46:39 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec5b2ec20435519b2da95e3f1bf527fc |
|
2021-09-03 09:04:01 |
Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a513a68901acc2a9b5af7f8d7dc0e328 |
Company Administration - Other
|
2021-09-07 08:54:49 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5a32661a9e30a51057c147a50e006986 |
|
2021-09-15 10:14:12 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/151a57c2dce7d12b9c047140e04b6cbf |
Notice of Extraordinary General Meeting
|
2021-09-30 15:58:54 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/baf372460bc589f8f32ab2c1ae23e5c4 |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-09-30 15:59:57 |
Appendix 4G and Corporate Governance Statement 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ccd1157dcf5aad5dc8fd0daf3a73b6b9 |
|
2021-10-14 09:33:30 |
GM presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53200925a2dab50327dfd4ac191d5f05 |
|
2021-10-14 13:51:49 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab36cf0720d4ed04972f343096dbdecd |
|
2021-10-21 10:00:57 |
Chile Ministry of Health Approval Granted for ZolpiMist |
1 |
https://app.sharelinktechnologies.com/announcement/asx/93582eae5b60f41d845e7edee9fd2192 |
Company Administration - Other
|
2021-10-22 08:20:07 |
SUDA becomes Arovella Therapeutics |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5235e98df4b82d28bf87606821156964 |
Company Administration - Other
|
2021-10-27 14:24:21 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7aafbda306439ed37e2fac6b36657789 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-11-10 09:34:31 |
Senior Management Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27ceb115213e82e83c6eafca43f53b7a |
Company Administration - Other
|
2021-11-10 09:46:39 |
Appointment of Dr Elizabeth Stoner as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c6f9751f2cf5d5e653137bff54743ce |
Director Appointment/Resignation
|
2021-11-10 12:40:36 |
Jobkeeper Payments Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a1cf1324b93b72d1858e2d6a0700b50 |
|
2021-11-11 12:17:16 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f6288990347c3a1538d77b78c319da7 |
Initial Director's Interest Notice
|
2021-11-11 17:59:54 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a1046b9f4dc080a29c0b1a3977c670e |
Appendix 2A (Application for Quotation of Securities
|
2021-11-11 17:59:55 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e26e52c6bc423074d78fc83c8e095a40 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-11-15 09:52:48 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f1b2e7e0bcdc00a2abb208851299570 |
Change of Director's Interest Notice
|
2021-11-15 15:27:22 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82a5d05ea91045d85f75c471d2092780 |
Notice of Annual General Meeting
|
2021-11-17 16:00:58 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edbd8d740093eecb205bb1d527a3dc95 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-11-29 13:17:11 |
R&D Tax Incentive refund received |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27371d4d0e1fc98f28321d335912a678 |
|
2021-12-13 09:29:21 |
Arovella licences novel monoclonal antibody from MD Anderson |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6530ee4a75f75066b0d512feab54c140 |
|
2021-12-16 09:48:36 |
AGM FY21 Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98aabb87db3c2edf0aecd2b98b9a241f |
Chairman's Address to Shareholders
|
2021-12-16 13:12:09 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/464fe9f8cb1c42a3220b832bd81e66b1 |
|
2021-12-17 11:03:00 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c30f5af46abba88ffe6ea4e640372ca |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-12-17 11:13:10 |
Change of Director's Interest Notice x 4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce08215f36f75768eee87397f2aff79b |
Change of Director's Interest Notice
|
2022-01-11 10:16:11 |
Arovella to present at Biotech Showcase 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f637986799246b1333d1f0a81a28d53 |
|
2022-01-14 14:40:37 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a45c635db06be2bd0b7f3d8a2bd6e3a |
Final Director's Interest Notice
|
2022-01-20 09:32:29 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f1424cdba7795cafd4058bf84b844cbb |
|
2022-01-24 10:31:26 |
Arovella Completes $4.57M Placement & Launches $1.5M SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14e500e221c2796161e71730455cf0e8 |
|
2022-01-24 10:31:44 |
SPP Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11684f9183ab9a9be8290597c35f5552 |
|
2022-01-24 10:32:48 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4ac9f1ea7d6d7ab401ee1f4bb3a2e09 |
|
2022-01-24 10:32:50 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/678de5e4e78d5bad353aba1cb39910a3 |
|
2022-01-24 10:32:53 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8aeaeff3ff17f257c0481ba07e491cc |
|
2022-01-24 10:33:23 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d195269682eb37b4a2ec7d5d9dd95c58 |
|
2022-01-24 11:25:23 |
Cleansing Notice - Share purchase plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f37a685482671d83d512d7bf734dd16d |
|
2022-01-25 09:17:15 |
Arovella Appoints New Cell Therapy Development Expert |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d676864b1869f7a29c90f72f05c194a7 |
Company Administration - Other
|
2022-01-27 10:43:31 |
Update - Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/720da52b38aa4155e1c9b5db3ebb28ce |
|
2022-01-31 08:34:10 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a8bcb0cac4c3e202179873476e0aa1ad |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-01-31 15:12:11 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30d4beb85c0bb87d0f0d6dd80ed9ea36 |
Becoming a substantial holder
|
2022-02-01 10:16:14 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6c761d9f60e675e3359f4e333100581 |
|
2022-02-01 12:35:34 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/762ecc4142b9cfe1cca5fdad22e4d0e5 |
Appendix 2A (Application for Quotation of Securities
|
2022-02-01 12:52:51 |
Section 708A Disclosure Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/515f0bec3845463a8aceb80faae5f726 |
|
2022-02-02 10:39:38 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af6a0f6d0291db57756cf2490805aeee |
|
2022-02-08 10:01:56 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be547090742aa02b4c751902ff82f98f |
Notice of Extraordinary General Meeting
|
2022-02-21 13:33:31 |
Arovella SPP Closed early over subscribed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77dbe3ecb7954a17033c520b2a1aa15d |
|
2022-02-28 10:00:57 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84c5d2fe0e9224e94a32de178682d13f |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-02-28 16:58:56 |
Update - Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2c1a61eae83ece1a5de54e9b5a18129 |
|
2022-03-08 13:03:00 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8d573c12bc500183b35fe2892bd2cca |
|
2022-03-16 15:21:20 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b9d5b291a2ff6430c28f7565454b241 |
Appendix 2A (Application for Quotation of Securities
|
2022-03-16 15:28:23 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31b2aeef7ca763bdd13cb05ad5ebee4e |
Appendix 2A (Application for Quotation of Securities
|
2022-03-16 15:39:36 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f3cf0f5905e0db0ccb757ea546a3e5a |
|
2022-03-16 17:53:45 |
Change of Director's Interest Notice x5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b098cf4ddeec0c29f5920ad35c165237 |
Change of Director's Interest Notice
|
2022-03-17 16:57:55 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0affd0d4a87a036c2a82b3ece638efb |
|
2022-03-25 16:11:10 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf4b5018c199968b307e04dd0ba29c2d |
Appendix 2A (Application for Quotation of Securities
|
2022-03-25 16:24:18 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/451a9f8a4107e69b94b816d40c8b170c |
Appendix 2A (Application for Quotation of Securities
|
2022-03-25 16:47:46 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/331b221a9eee3c0e02fbc2f3232fc2c0 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-03-25 16:54:53 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f9566068bacffeec4ec860653a6c569 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-03-25 17:00:59 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e734e5a13c0eb7e8e58f9652c3d446e |
|
2022-04-05 14:14:12 |
Anagrelide patent for the United States |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdfb85a9e3d6cb2ebe75234e2912131d |
|
2022-04-20 11:10:07 |
Services Agreement with Q-Gen for CAR19-iNKT manufacture |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fcfae08f5e90b51456611811a1876ff3 |
|
2022-04-28 11:38:35 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b90c409a68f2e2d53d765e9da7fed18 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-05-27 11:42:41 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c6810877c9419cca44d7a78b6817dd2 |
Details of Share Registry address
|
2022-06-07 09:24:22 |
Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82eedf27c9690162c80d7424ad0659e6 |
Director Appointment/Resignation
Company Administration - Other
|
2022-06-08 10:11:08 |
Arovella Therapeutics Adopts WEF Framework For ESG Reporting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/41c0e0269e565119dba84b0831a45bdc |
Company Administration - Other
|
2022-06-22 10:02:00 |
ZolpiMist Launch Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d95baeb1574e810840709968fd1d98fb |
|
2022-06-28 09:03:59 |
Sumatriptan Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa587033d0ba63482a80c9366c83ccb8 |
Company Administration - Other
|
2022-06-29 17:01:01 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bc001a7cdbd676fc9142373bf02cfa7 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-07-01 08:57:53 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14cfac3726eb4ff1c5f133c5b46701dd |
Final Director's Interest Notice
|
2022-07-01 09:13:11 |
Appointment of Mr Gary Phillips as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cef88f8401c328b11e3965554335465 |
Director Appointment/Resignation
|
2022-07-04 15:37:35 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06a32fb757e1c60fc75f97569d128fa2 |
Initial Director's Interest Notice
|
2022-07-14 15:46:42 |
Letter to Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e750b439f77b287e7f4ce0ba5e739bed |
|
2022-07-29 08:46:42 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56f744bcfc01a2f22029428eed1071dc |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-08-01 15:59:57 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81f99dca61238fb2b6eddea0256e10a1 |
Appendix 3H (Notification of cessation of securities)
|
2022-08-01 16:04:02 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fb3379db69c20818334e52d4f72ed65 |
Appendix 2A (Application for Quotation of Securities
|
2022-08-31 10:22:19 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f3bc80a641cd7934d9c77daadfae816 |
|
2022-09-15 15:14:12 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43abd2417c4f1fa4b5cccee8355d804c |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-09-19 15:30:28 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/171228cb6c5a7a67961d1b89ed251014 |
|
2022-09-20 17:36:34 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d864f5c06da1f6fc1619accb2b04a2f |
Appendix 2A (Application for Quotation of Securities
|
2022-09-20 17:49:45 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a61f42a64714695f093c980230d3f28 |
|
2022-09-26 09:55:34 |
Preclinical trial of ALA iNKT therapy and IMU onCARlytics |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ccef481d927c5bc77530e7479a3250aa |
|
2022-09-26 10:33:28 |
Investor Presentation Imugene Arovella Therapies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8aef3f85dcca2e569dfe0f2ded4aeacf |
|
2022-09-27 09:01:56 |
ALA iNKT therapy and IMU onCARlytics - correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3422642a4a230b2a790145773f083ba4 |
|
2022-09-29 10:03:02 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b7db26db710555b9504524e358c77a1 |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-09-29 10:05:03 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d7c282a7f5e7f5a318f2a101693bfc8 |
|
2022-09-29 10:05:05 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/572f6dc6c0e1af95a23969666ba60928 |
|
2022-10-19 11:50:45 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52f9996b7313c180db40e4f56b131d3a |
Notice of Annual General Meeting
|
2022-10-26 09:25:20 |
Arovella to close its Perth OroMist R&D Facility |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3aece45413e6ae22147117324a3e9dc0 |
Company Administration - Other
|
2022-10-31 09:27:24 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0a143f04ed3b22c4922d97b6aeb5bdb |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-11-07 10:14:08 |
Europe Patent to be granted for iNKT Cell Therapy Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/45001e18bd2e10d5f119b188ac56e811 |
|
2022-11-17 09:18:16 |
Arovella to present at Biotech Showcase 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44d3df5d4267373b8ccd8ea2944b3b8c |
Company Administration - Other
|
2022-11-17 11:26:24 |
AGM FY22 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7baf134be6aefad7fe34b1c0a6b12029 |
Chairman's Address to Shareholders
|
2022-11-17 15:23:21 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/473a4b8a8f51936ca258bbdcf5a58778 |
|
2022-11-29 10:59:54 |
R&D Tax Incentive refund received |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89be16cb40b14d9253125a85b169ba5a |
|
2022-11-30 12:55:52 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cab11a2d50750c74e48fe4b04ad121c |
|
2022-12-01 10:28:27 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03a354740d357112f9a9900a1c92511e |
|
2022-12-02 15:48:46 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d59418b3d6904b475b801b6dc24121bb |
Appendix 2A (Application for Quotation of Securities
|
2022-12-05 13:25:24 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab0348ef7810b05c439d7a1d59cf2cf7 |
Appendix 2A (Application for Quotation of Securities
|
2022-12-05 13:28:27 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e6c0da0d18be265fdd8dd6034f161ad |
|
2022-12-05 13:31:29 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/febbd004a27114d727954518fb8e83cc |
Change of Director's Interest Notice
|
2022-12-13 16:51:50 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad04b6da9b9c9b9813d0212e6c8cbf03 |
|
2022-12-14 14:37:36 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ac0c8423b1f1ec8d3cb331396377f48 |
Appendix 2A (Application for Quotation of Securities
|
2022-12-14 14:40:39 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b8f5cbb8f5538dfc925d1f2cedf63dd |
|
2022-12-15 17:34:32 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38f33d3aad4a82a4bb6662b4a4e51939 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-12-16 10:47:45 |
Change of Director's Interest Notice x4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97e9b030ecf2007c267fb1c471c31109 |
Change of Director's Interest Notice
|
2022-12-20 08:58:55 |
ALA options cytokine technology to enhance iNKT platform |
0 |
https://app.sharelinktechnologies.com/announcement/asx/129706201f95eb8d4ba241c7cb40ccec |
|
2023-01-03 11:36:34 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc1ee9208aac0e41a3ad73a8fb3f0a80 |
Appendix 3H (Notification of cessation of securities)
|
2023-01-04 09:39:36 |
Arovella appoints Chief Operating Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b3d0f06a57be5c8fd1134a779fd43b5 |
Company Administration - Other
|
2023-01-11 08:58:54 |
Arovella Biotech Showcase Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95eae8f202f9fff4605a3c4525598df9 |
|
2023-01-17 09:41:37 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e8e6178bf317ff84fa231ff86c35902 |
|
2023-01-19 10:02:43 |
AROVELLA COMPLETES $1.65M PLACEMENT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72f90646d8fe1ca0ce826cd2ee0e9dc7 |
|
2023-01-19 10:03:51 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73ec3f064618c5224883c0da026197fb |
|
2023-01-19 10:06:52 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1358d6ba444c1137d6d6617b7efbb5cc |
|
2023-01-25 11:42:41 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/792ea22d49a5f54a02cd3ab0e1e39177 |
Appendix 2A (Application for Quotation of Securities
|
2023-01-25 11:46:45 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/564f899414dd3683e7bb10f87c489b28 |
|
2023-01-27 12:15:14 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdb4713a346556efabd56916f392cbfd |
Appendix 2A (Application for Quotation of Securities
|
2023-01-27 12:20:16 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e9e9b7ad25342cf77233420f08a9fd0 |
|
2023-01-30 14:35:33 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e27576b4d88e1c9d87c7c7f7cfa16ad |
Change in substantial holding
|
2023-01-31 09:02:58 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b13db0b81c2f71afcd8e888d2114fbe0 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-02-06 10:17:14 |
Arovella to present at AACR conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0313c97fedb4e21c52e20dc2a9bf570 |
|
2023-02-10 09:23:17 |
ALA and IMU collaboration advances to next phase of testing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc8ac60de7d989b6e35b536e9938eb43 |
|
2023-02-16 12:18:16 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c400982d62ccd4ef7caff75ac226eb6 |
|
2023-02-17 15:28:27 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/377a9bc73b4f76c249336e1c481c6c88 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-02-23 09:41:39 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee52a07a6d83d0ca68a80cb9a2fc8abf |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-02-24 08:11:04 |
Arovella presents at Spark Plus Biotech Day in Singapore |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a34c094ee84dba9d759023c72214723 |
|
2023-03-03 17:25:23 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da797884be9e996ca4e5608dce973bf0 |
Appendix 3H (Notification of cessation of securities)
|
2023-03-08 09:54:53 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99a6bf0a4f6576fea83b04a53a0ab484 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-03-10 17:03:02 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77d501b73eaa99c1a07b2aec5491ad7a |
|
2023-03-13 08:21:04 |
Arovella appoints Dr Thomas Duthy as Non-Executive Chair |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa6095fb788d7ec8e8f7a288f4737d4e |
Chairman Appointment/Resignation
|
2023-03-13 08:53:52 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8dbe5191a9e95f6d9b9afe96258d2b33 |
Initial Director's Interest Notice
|
2023-03-13 09:15:13 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/778ee22e05bb76a1ecaa6d5ef906dda9 |
|
2023-03-14 17:16:15 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e808181f8a9d4f26d084671aa9efcc90 |
Appendix 2A (Application for Quotation of Securities
|
2023-03-14 17:21:20 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04f8371db2e8cae8a1d242c7ba13403b |
|
2023-03-16 08:19:09 |
Arovella to present at NWR virtual healthcare conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a60148169aa3c21db94ba7e4e1fb8b81 |
|
2023-03-23 08:48:45 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da7ed49df368e875088eff693b3b1fa4 |
Notice of Extraordinary General Meeting
|
2023-03-28 12:41:38 |
Arovella iNKT Cell Platform Explanatory Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63192ddb0c1f76ae704766f59f50da1d |
|
2023-04-04 09:24:57 |
Explanatory Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05b41e46a420bba98c721254fa974269 |
|
2023-04-11 15:52:51 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2754b16bc47c2091a942b7e5b10752dc |
Change in substantial holding
|
2023-04-14 14:59:56 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b0eb3339d9d736fd905cf6b03ce59b84 |
|
2023-04-17 08:46:43 |
ALA-101 confers survival benefit in leukemia model |
1 |
https://app.sharelinktechnologies.com/announcement/asx/254d664f49adcf883d589b813cd5d0b6 |
|
2023-04-19 09:33:26 |
Arovella AACR Poster Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94fc75d4d77e459f7f1402c2cb04457c |
|
2023-04-19 16:46:45 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e311f228e90c7348fea2c73a61eb2a9 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-04-20 09:52:49 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a1f172f37795605defcd2301467f12f |
|
2023-04-21 09:24:20 |
Chairman's address and CEO's presentation to EGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29c6f4ac1e01e227f080a5135bad15bd |
Chairman's Address to Shareholders
|
2023-04-21 11:54:51 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a290231f9ca322724e933b101a6fbd84 |
|
2023-04-21 16:20:19 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3dbb10f053ac42ddece1536ee7dd08a5 |
Appendix 2A (Application for Quotation of Securities
|
2023-04-21 16:22:21 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ecded03d9fe625f757a6be0a5e297a6 |
|
2023-04-24 09:55:53 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/546e5c098b0caac2495b69b287eaa562 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-04-26 10:47:44 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5477b6726a26aae7c9958182c8f6871f |
|
2023-04-26 16:59:56 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/23f0454d3be67bea1674c28f51d2d357 |
|
2023-05-01 09:40:40 |
Arovella's OroMist R&D facility closure completed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e88e570dd23e99b7d8124ac8e636c2ae |
|
2023-05-05 16:17:15 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab2e6fbf65b57434e2a8c1ae5a312b29 |
Appendix 2A (Application for Quotation of Securities
|
2023-05-05 16:19:17 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c38cf3b4691ca2710c20712a116335e |
|
2023-05-05 16:21:19 |
Change of Director's Interest Notice x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c335bb90675cf169aa181c0660d7fc2 |
Change of Director's Interest Notice
|
2023-05-22 11:41:40 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79aeed4d79637af942e7017f4f6ffec4 |
Change in substantial holding
|
2023-05-25 08:23:49 |
ALA presents at the 5th annual Allogenic Cell Therapy Summit |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5975d29cd271c6a7525821557004fadc |
|
2023-06-05 08:58:57 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2eceb0bf5e5d22d0a6e9871b545ccba8 |
|
2023-06-07 10:23:36 |
AROVELLA COMPLETES $4M PLACEMENT & LAUNCHES $1M SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b6945abada987cd48d85d3f6c4bb2db |
|
2023-06-07 10:24:16 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/134c2b49585c4b77c10b4893c62aca3e |
|
2023-06-07 10:24:39 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e102d2dcde507721ea64081d9b22a16 |
|
2023-06-07 10:24:44 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/537028b8503dbd6f14a2c8aaf8648571 |
|
2023-06-07 10:24:57 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8bba425a5c7083194223fa9e2e5cc00 |
|
2023-06-14 10:18:17 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b69abb0c38b26e149bcabca35fe86bf |
Appendix 2A (Application for Quotation of Securities
|
2023-06-14 10:24:23 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fac01bbcedafd00e5adb71ab4ce60882 |
|
2023-06-15 08:26:22 |
Share Purchase Plan (SPP) Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e9a7a150edcd0b2bef365e49cc1ce10 |
|
2023-06-19 10:01:00 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0272f13c5269b1932ba6de5f176e654a |
|
2023-06-21 08:36:34 |
Becoming a substantial holder RM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8110e62387557e3fe4c80dbf690b3f75 |
Becoming a substantial holder
|
2023-06-22 10:11:09 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/924ce428c2c2161d186a220c30133c7e |
|
2023-06-26 09:23:19 |
ALA advances iNKT technology option with UNC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/542f30cdab1d05134ab7d627b93336d8 |
|
2023-06-26 16:21:20 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1a88a38e8dba8f5b4de48238a72ba00 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-06-27 11:20:17 |
ALA advances iNKT technology option with UNC - supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c0ea72a930f4a2d093ef43cccb1950e |
|
2023-06-29 09:11:09 |
Share Purchase Plan (SPP) Closing Date Extended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de6723e8656f828c99a20154065d679f |
|
2023-06-29 09:16:15 |
Update - Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/08bbbf040d59bc3f968d90e7e285d440 |
|
2023-07-11 08:43:41 |
Completion of oversubscribed Share Purchase Plan (SPP) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e5d867f31d26b208d0a7b7d16ea4d1b |
|
2023-07-11 08:46:44 |
Update - Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30ee324984b5c92279752c3e13d22def |
|
2023-07-12 08:57:56 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffbc92b7aad8b76689f4a6a154aee61c |
Appendix 2A (Application for Quotation of Securities
|
2023-07-12 12:20:19 |
Change of Director's Interest Notice x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f4aa85c8a95aa88e136842fdf3244ad |
Change of Director's Interest Notice
|
2023-07-21 17:02:58 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d6007d9b3b91b7c5cf1f3ba43c1b974 |
Notice of Extraordinary General Meeting
|
2023-07-24 10:41:33 |
Quarterly Appendix 4C and Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/375c173d4b3cd0ffa01b84138a7ba6cc |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-07-25 09:12:55 |
ALA presents at the 17th Annual Bioshares Biotech Summit |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c1720be29d37556ad7ca5a4c8c18c3c |
Security holder details - Other
|
2023-08-02 12:34:33 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7b769d24eef8f15ad177665f5016f49 |
Appendix 2A (Application for Quotation of Securities
|
2023-08-02 12:40:39 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da9a0ffbee7d9dc813af50e9162064c0 |
Appendix 3H (Notification of cessation of securities)
|
2023-08-02 12:44:42 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbffb6285ca389cb1392d83bf79a8126 |
|
2023-08-15 08:05:51 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60be629eddc9388e265aec2a0482d73c |
|
2023-08-23 11:56:52 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed71f3c45dfd07832ae28df3ed7d5d37 |
|
2023-08-25 09:11:10 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/422f9f25a4dd19ce7e2690d8d605f628 |
Appendix 2A (Application for Quotation of Securities
|
2023-08-25 09:17:16 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df8962064452cb4235a54fa469239280 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-08-25 09:21:19 |
Change of Director's Interest Notice TD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6f988fb70dfccf4068aec9a6730e21a |
Change of Director's Interest Notice
|
2023-08-25 09:23:21 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7da361c560e8b51bc50c346be5c7d2d |
|
2023-08-31 09:35:32 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b236c633272816c569da02844f6e4dbc |
|
2023-08-31 10:16:13 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a9187143d9b28c716820499e5d9831d |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-08-31 10:19:17 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b143fb0a7eaac8e01f3ab8bb95f8fdcf |
|
2023-08-31 10:21:20 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b615de3addc4fb22168e9d2d711aa29c |
|
2023-08-31 14:38:36 |
2023 ESG Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8d5de58b63968c21ac1dd7492a4f994 |
Sustainability/Climate Action Report
|
2023-09-06 09:13:28 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d14bb1500842d69ab30c82d8547d070f |
|
2023-09-07 12:57:55 |
Board Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9a30920a78b8fce78c34c8fc663caa9 |
Director Appointment/Resignation
|
2023-09-22 12:38:37 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d28ff3d274787bc816fe0dd3e40b472 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-10-09 09:20:18 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d38044fd284a478d33270a959b1a068f |
|
2023-10-11 10:40:38 |
Suspension from Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/259ffe6e3e958de19400b329cd21676a |
Suspension from Official Quotation
|
2023-10-12 09:18:45 |
Arovella licenses novel solid tumour targeting technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8ab02736ab0433519434d48c4f9d12a |
|
2023-10-12 09:19:17 |
Reinstatement to Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0f34171be474e87e63f82c1c4e17e6bd |
Reinstatement to Official Quotation
|
2023-10-12 09:29:28 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebd3ceadf5df7200a2f127307d216faf |
|
2023-10-12 09:52:47 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c33f7804d3be28f87f0554ef259aef08 |
Notice of Annual General Meeting
|
2023-10-25 16:54:53 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/599c1496acfbcc3da60525b3b8daf29a |
Appendix 2A (Application for Quotation of Securities
|
2023-10-27 12:42:38 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1f1d60e04d7c6ba6f5dc7b0b2721410a |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-10-30 09:42:28 |
AusBiotech Invest Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bebb3ef9a1d435174e93ce25ade1025d |
|
2023-11-03 08:22:12 |
Emerging ASX Gems Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dacdcd94764432d03f10adf386d89482 |
|
2023-11-03 17:12:11 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11c0aeb52bb65976550eb8eb6b2b5732 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-06 09:48:44 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5bd7f8e08484deba2c3834365d3b79a |
|
2023-11-10 08:53:50 |
AGM Chairman's Address and CEO & MD Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4f691d829570347596bb8418282a0b1 |
Chairman's Address to Shareholders
|
2023-11-10 12:07:06 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8c7bb79ebdbd2b4a73acfcb2bb56038 |
|
2023-11-13 08:33:15 |
DKK1 program update following strategic pipeline review |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53d01f0110acd0b96d255c9aec8aa715 |
|
2023-11-13 12:45:44 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65e26b3f58d656b8193495f3840df15b |
Appendix 2A (Application for Quotation of Securities
|
2023-11-13 12:49:48 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f860c47112413a6dc688b3fa1c2a5058 |
|
2023-11-17 16:43:42 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37f6b461379506992636c84c66b0c956 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-17 16:46:44 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d558db811d213c3c5464e57e055306d1 |
|
2023-11-20 13:12:11 |
Arovella receives R&D tax credit of $1.94 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6cd5e19e6573c412cf3eec9a15413db |
|
2023-11-21 11:02:57 |
Monsoon Twilight Investor Briefing Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7a4d67688639c914d36b6cbea5b2b9e |
|
2023-11-23 11:53:50 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28320c048a166c66884b92f4c9545a56 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-23 11:54:52 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e30aa9ba70adce0e291087df3237d2a |
|
2023-11-23 16:57:56 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52dae70772f92808b86a4a719878e06b |
Appendix 3H (Notification of cessation of securities)
|
2023-11-28 17:46:42 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1ce412788025854342afe4a0971e356 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-28 17:50:48 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e73510d8b274864387a8db8920e2d5a8 |
|
2023-11-30 10:37:26 |
Update - Notification regarding unquoted securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbdf844c81ff781f5d451ca984d8b1d6 |
Appendix 3H (Notification of cessation of securities)
|
2023-12-01 13:27:24 |
Company Secretary/CFO Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e2d11f31ba404b377932403c89383ae |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2023-12-04 08:40:22 |
Update on ALA-101 and onCARlytics research collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/915bb456393d6d7af299880b00069994 |
|
2023-12-06 08:16:48 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b966ec9e53fee1110c1c82bfe91d51b |
Appendix 2A (Application for Quotation of Securities
|
2023-12-06 08:54:52 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d801f569e3c4c2e3baaacc04e825a0f6 |
|
2023-12-06 17:52:50 |
Change of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/adf34291bb7a47980c7d6f2821823bc5 |
Details of Registered office address
|
2023-12-07 08:28:27 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/671e4e699c19c0ae87951dc0578a1031 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-08 09:24:23 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/710402aad01820ba5875b5e8ec985ef0 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-08 09:29:26 |
Change of Director's Interest Notice x5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aec977550d453e6352bd711b38356bc4 |
Change of Director's Interest Notice
|
2023-12-11 08:46:38 |
CAR-iNKT Cell Platform Data Presented at ASH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71a275d27ca0108b8a47a821f11ef451 |
|
2024-01-02 09:29:29 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65c0d98c3566b0abcd8d922ca4e7aa02 |
Appendix 2A (Application for Quotation of Securities
|
2024-01-02 09:30:30 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bfe18c0e63b3d269289d4b2fa8899cf |
Appendix 3H (Notification of cessation of securities)
|
2024-01-02 09:44:41 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b17c974b0ebd62e7f697be8cdd03bf5 |
|
2024-01-02 09:45:43 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12c4fc114ee53c8bc8744d2627308c17 |
Change of Director's Interest Notice
|
2024-01-02 11:13:11 |
ALA completes key manufacturing step to progress to clinic |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de9950f8c6ff7550c907ca7e2aed30e5 |
|
2024-01-04 16:31:30 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97778745b4db9a025b0b0b8c8f8e5cec |
Appendix 2A (Application for Quotation of Securities
|
2024-01-04 16:34:31 |
Notification of cessation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9123c6193be0bdeb815ebc6b2213777 |
Appendix 3H (Notification of cessation of securities)
|
2024-01-04 16:35:33 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aeb62ac95fdda2515e4101a5f62c2d28 |
|
2024-01-08 14:23:23 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cdb28fb49981bf7bff111b9927a4a30 |
|
2024-01-10 10:52:51 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a80660edd0415cb762eeebd3435dec6 |
Appendix 2A (Application for Quotation of Securities
|
2024-01-10 10:57:52 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdaa2ca2dff48ea2ebd28202d61e7b70 |
Appendix 2A (Application for Quotation of Securities
|
2024-01-10 11:17:57 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4914faef3885978551aca7e238d4c48 |
|
2024-01-16 17:00:58 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c881ccad48bc0f3c12f0af61f28bebb |
Appendix 2A (Application for Quotation of Securities
|
2024-01-16 17:04:03 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99779631d2b6ceef6ff5fd6236abb59d |
|
2024-01-19 16:00:59 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/263428d41b7adb4e64ef56f9d70c83ba |
Appendix 2A (Application for Quotation of Securities
|
2024-01-19 16:04:01 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9c14f90b2d3a4609328f1b20278dd4e |
|
2024-01-25 12:30:27 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78de7c87d18ef9dac475ae95653adfa3 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-01-29 08:36:34 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a6ab30e9cfd15104df06a19e956ac30 |
|
2024-01-30 09:57:51 |
Arovella licenses novel CAR-iNKT cell armouring technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1af6a7ddfc902d70a420bff6ec809b4 |
|
2024-01-31 15:13:12 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b580e16aaf17fbe0d0e71d414795fea |
|
2024-01-31 16:14:13 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e024bdcfb386573cbc7b720aaad462ec |
Appendix 2A (Application for Quotation of Securities
|
2024-02-13 09:18:17 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0847055d77bc236d62d611160a18af5 |
|
2024-02-14 08:22:42 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c94818de0eaa5e1ceaeeaf2c42571e38 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-02-20 13:17:15 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d8f1d82fb58c3dfbe400051cceb1aff |
Appendix 2A (Application for Quotation of Securities
|
2024-02-20 13:21:19 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c046501f04715b9821124edc02495d2d |
|
2024-02-28 12:43:39 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fae3b8fff90b79f43f22234234b8d98e |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-02-29 10:20:19 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63530ca78aa842176d3650502e11064d |
Appendix 2A (Application for Quotation of Securities
|
2024-02-29 10:29:28 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e1fe869278d5e8100841cd4179c9af5 |
|
2024-03-01 08:35:32 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/622dafd5033b73e2682b1fcb22df5f82 |
|
2024-03-14 11:16:15 |
Spark Plus Singapore Healthcare Day Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79e8839e54d750db1b2ad44e4fd2f882 |
|
2024-03-19 10:23:22 |
Arovella to present at NWR virtual healthcare conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81ee0f81c19896f05fa562f4513cbc8f |
|
2024-03-20 08:52:50 |
ALA-101 and onCARlytics collaboration update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05277e2b0bc37926515c125ed9cd6802 |
|
2024-03-20 09:11:10 |
NWR Virtual Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c616f4b64b8e775644486d07550b5ce2 |
Company Administration - Other
|
2024-03-22 09:50:49 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d76f0554371df65d698a539c82e71452 |
|
2024-03-22 09:56:55 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c607ab0fc4a8c3d35dc11ae45b7e584 |
|
2024-03-26 09:38:18 |
Arovella Completes $12.5M Placement - Funded to Phase 1 Data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9daafd455c828a86f0d55fd96a51ecd7 |
|
2024-03-26 09:38:33 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1de6951737fe5165415d4c591e9dd6e |
|
2024-03-26 09:38:37 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15a06d4c858f09bdced19617adc34271 |
|
2024-03-26 09:38:38 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c6d5cad41579b00b0c1176f7fb7bcab |
|
2024-03-27 10:55:53 |
Arovella to present at AACR annual meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7628513df1bed9e6f4f071e8948ed7e |
Company Administration - Other
|
2024-03-28 09:49:47 |
Change of Director's Interest Notice - MB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5da76cb7258fab324d2fa5d60248ac3 |
Change of Director's Interest Notice
|
2024-04-02 08:31:06 |
Change of Director's Interest Notice - TD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ad714fdea175253a0841c516e6f19fb |
Change of Director's Interest Notice
|
2024-04-03 08:28:26 |
Change of Director's Interest Notice - GP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b124ae9a27056bc50027390d9f6602e |
Change of Director's Interest Notice
|
2024-04-03 10:18:15 |
Prof Gianpietro Dotti appointed to Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3bd5a381d78108a00ddaf291e9cafbf |
Company Administration - Other
|
2024-04-04 10:45:44 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f92236225018ee0990e7c4521c7e1fc |
Appendix 2A (Application for Quotation of Securities
|
2024-04-04 11:04:51 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ae811d19662e42c99f4107b437167e5 |
|
2024-04-09 08:56:54 |
Arovella presents ALA-101 data at AACR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d4dc418277878a491d30c6215f9ac63 |
|
2024-04-10 13:51:49 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cd4363f50923a94177c8c07f775ca60 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-04-23 13:26:22 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a6785b5c415dc11d242c4fa0a7d1b86 |
Notice of Extraordinary General Meeting
|
2024-04-23 13:41:40 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0198266d001920488d1edef26eb37e0 |
|
2024-04-30 09:51:46 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/563b4b39cbe5184d6febaba12a7ba536 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-05-01 11:38:36 |
Updated Share Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dcb4c5f51c13ad751605f056bc5fcb66 |
|
2024-05-23 10:54:53 |
EGM Company Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9de727562009f235ba0f7d035010be2a |
|
2024-05-23 15:51:50 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c9b9542f6d8bdf83d2f58b68bffcd0d |
|
2024-05-24 16:44:43 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43e76fd5e19713b8ccbb1dffb6374320 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-24 17:16:45 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bbba9963d6b43e1cddd942d2dd64f11 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-30 08:27:25 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ee7054fb2112f792422c56d0d68103d |
|
2024-06-05 09:16:15 |
Arovella completes manufacturing scale-up |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41610934e63dd00e24ab66c8c4f8c9c8 |
|
2024-06-13 08:24:09 |
Zolpimist Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/924bdbb25b89d0df0eb799b38b1afaa8 |
|
2024-06-18 08:22:22 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3661dadfc2b7df1b67a7778d6696cef |
Appendix 2A (Application for Quotation of Securities
|
2024-06-18 08:25:24 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdc39dc3ec189ff72f90cdddb137ec92 |
|
2024-07-03 08:56:54 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee294b94f1369f1ec6da5cf9da0a52f9 |
|
2024-07-03 15:28:26 |
Proposed issue of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7260f936a81bc98ce94f9149d939231 |
|
2024-07-04 11:13:12 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7b4a4f2bd2963625bf8b481653c42d5 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-04 11:24:23 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e69256309e55bfefe94be0d665cd0e3 |
|
2024-07-19 08:15:53 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e54f160ea16a2c52bf5439b0a4fb7420 |
|
2024-07-23 16:47:46 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c21edd0b184f2e3e9e9d5a97964b8f6 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-23 16:49:48 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c781adc5782275693c7287eacc78331d |
|
2024-07-25 09:34:33 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65b226a1a71c444f6e1e7e50bac4fd23 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-08-07 09:21:16 |
Positive pre-IND feedback from FDA for ALA-101 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0acf5cf5a86b4adc4ac395e3e0c8ff5b |
|
2024-08-22 09:43:39 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bbd21f61355a867cc0b49da3e948d689 |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-08-22 09:44:43 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b327569ccad218e5161863401a1e834 |
|
2024-08-22 09:46:44 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eecae2da7c99a8716bad585772b98e77 |
|
2024-09-10 09:58:57 |
ALA presents at Cell and Gene Therapy World Asia Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72f86abb9228069d655dbef64d95233c |
|
2024-09-11 10:32:30 |
2024 ESG Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05d575e500eabb4ed2a0597c7da99c03 |
Company Administration - Other
|
2024-09-12 13:27:25 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/becf9d50305533fd7f9b5b174f450770 |
|
2024-09-12 17:18:16 |
Updated Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73e7a79f733b4b5d5a3d7cfd649c7d83 |
|
2024-09-18 09:05:03 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95ba9c9fdd9c9465a1d2f9e700e11aaa |
Change in substantial holding
|
2024-09-18 09:09:08 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c6a180de21a2913c3fc7b2f8a729d66 |
Becoming a substantial holder
|
2024-09-18 10:30:26 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6539745a75f93ede8f11be8d2f183358 |
|
2024-09-19 09:51:51 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb499883cfb71a79e7732778b8050c2d |
Appendix 2A (Application for Quotation of Securities
|
2024-09-19 09:54:54 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a903990fcb379a8e2433dd39e467cea3 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-10-01 12:56:55 |
Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1c17a98bafa8f38cc95a3b066a920d3 |
|
2024-10-07 15:26:25 |
Notification regarding unquoted securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4615f4aa066e6597bb52b208d477a3b9 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-10-09 11:05:02 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2946729a6a514c15de329caef15fd1ca |
Notice of Annual General Meeting
|
2024-10-14 09:47:45 |
Clinical Advisory Board established |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0495d250f0dbe97944a7bc0f0922dbbe |
Company Administration - Other
|
2024-10-16 08:23:55 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7d439a37bfe1c0d0520ec2038c24b20 |
|
2024-10-16 16:36:36 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ae0df02e2cb3aa0aa67322e67420137 |
Appendix 2A (Application for Quotation of Securities
|
2024-10-16 16:40:39 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1d7a0ab2e787f23fefe455f4b765e0a |
|
2024-10-18 10:13:12 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29f9804ed8035359b3cfbe6f397e8419 |
Appendix 2A (Application for Quotation of Securities
|
2024-10-18 10:15:15 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d87f63c6a12c4eabdb9e2bd76e196404 |
|
2024-10-24 08:21:18 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/167297c071c446099bb338b7a902ca36 |
Appendix 2A (Application for Quotation of Securities
|
2024-10-24 08:37:36 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eaf0d9556e8380a0fbe63e2d5c68b112 |
|
2024-10-25 10:55:53 |
Arovella receives R&D tax rebate of $3.0 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1f28bfde72e5e41e99b3b56d63a780d |
Company Administration - Other
|
2024-10-29 08:11:02 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84340a3c4ab47eac4e0c511dbfbc6158 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2024-10-29 08:37:31 |
AusBioInvest Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c750bbfd1eb4c652c6af27a941ca792 |
|
2024-11-13 09:37:35 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5e31eac1c19e4ed4d1b524688427ba6 |
Appendix 2A (Application for Quotation of Securities
|
2024-11-13 09:46:41 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ed391a7423675f0a489863b9386d135 |
|
2024-11-15 09:26:23 |
AGM Chairman's Address and CEO & MD Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70aac34e217081b8a69ffd06b1fc4692 |
Chairman's Address to Shareholders
|
2024-11-15 15:41:40 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/599d84123fb91285e606b893559cb440 |
|
2024-11-15 16:25:24 |
Application for quotation of securities - ALA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/317b0ae8b4f23c65a1de6575feefd3b4 |
Appendix 2A (Application for Quotation of Securities
|
2024-11-15 16:30:27 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2043179ebb7d4c40aedbe4072ad93ea |
|